Full Report

Fixed regulation_table: branch 6 (the AI row) was missing the trailing implication column, making it 5 columns vs 6 in every other branch. Added an implication value ('Widens performance dispersion; tech-native GPs gain a sourcing and ops edge') so all seven branches now return the same six columns in the same order. No other content changed.

---

Know the Business — Partners Group Holding AG

Bottom line. Partners Group is a Swiss-listed, asset-light private-markets toll collector: it builds bespoke multi-asset private-markets portfolios for institutions and wealth clients, charges a stable ~1.24% management fee on USD 185 billion of AuM, plus carry, and converts that into a 60% EBIT margin and a 55% ROE that almost no listed asset manager outside the alts cohort can match. The market is most likely underestimating the durability of the bespoke-mandate moat and the wealth-channel runway, and most likely overestimating how soon performance fees will normalize to a steady-state mix. At the FY2025 share price (CHF 982) the stock trades on ~20x earnings and a 4.3% dividend yield, the cheapest end of its 10-year range, but earnings are cycle-fattened by a one-year +60% performance-fee snapback.

1. How This Business Actually Works

Partners Group is not a fund. It is a fee-collecting platform built on long-dated client commitments. Clients — pension plans, insurers, sovereigns, and increasingly wealth platforms — hand the firm capital with multi-year (often perpetual) contracts. Partners Group invests across four private-markets asset classes, and earns three revenue streams: an annuity management fee on AuM, a back-end performance fee on profits, and a small balance-sheet line from co-investing alongside clients. Revenue scales with AuM, marginal cost of the next dollar of AuM is close to zero once the platform exists, and roughly 60% of incremental fees drop to EBITDA.

Two features explain almost everything else.

The fee margin barely moves. Across the FY2015–FY2025 decade — through a 2018 sell-off, COVID, zero rates, a 2021 mega-cycle, the 2022–24 fundraising downturn, and a 2025 partial recovery — the management-fee margin stayed inside a 1.18–1.33% band. LPs are not negotiating PGHN down on price (clients pay for the bespoke-portfolio-construction service, not just the fund), and mix shifts between strategies and structures roughly offset.

Performance fees are the call option, not the engine. Management fees grew +7% in 2025 in reported CHF and ~+12% on constant currency. Performance fees grew +60% in the same year (CHF 819m, 32% of revenue, vs 24% in 2024). The first line is what compounds with the franchise; the second line is what makes any given year look great or terrible. Management guides the performance-income share to settle into a 25–40% band — a typical year is closer to 30% than to 32%. Pay for the annuity; treat the carry as upside in good vintages.

Cost structure is 90% people and offices. Bargaining power vs LPs is moderate and asymmetric: high in good vintages (mandate clients have already integrated PGHN into their portfolio plumbing — switching is operationally painful), lower in slow vintages when LPs squeeze on side-letter rights. Bargaining power vs portfolio companies is structural: PGHN owns or controls them. Bargaining power vs distribution is the one to watch — every wealth-channel partnership is a multi-year AuM tailwind, but PGHN must share economics with the platform.

2. The Playing Field

PGHN sits mid-pack by scale but at the top of the table on operating economics. The US giants (Blackstone, KKR, Apollo) are 4–8x larger by AuM and 4–5x larger by market cap, but they earn their revenue through different mixes: BX and KKR carry large insurance balance sheets, APO is two-thirds credit/insurance, BAM is real-assets-heavy. PGHN's three closest economic comparables are EQT (European private-markets pure-play, same four buckets), Hamilton Lane (bespoke private-markets solutions provider — closest match for the mandate business), and Bridgepoint (smaller European PE/credit GP). The big US alts are scale benchmarks, not direct comps.

Sources: Yahoo Finance market caps (May 2026); AuM from latest FY2025 filings. KKR EBIT margin marked "n/m" because consolidated revenue includes Global Atlantic insurance net premiums that distort the gross-margin line.

Three things stand out:

PGHN earns the highest EBIT margin of any listed alt and the market is paying the lowest P/E for it. Only Hamilton Lane has a comparable margin/multiple combination, and HLNE is a tenth the size. The dispersion is not about earnings quality — it is about growth (management fees in CHF are growing slower than at BX in USD) and about the 2025 stock fell 20% on guidance reset and FX.

The Hamilton Lane comp is the most informative. HLNE runs a bespoke-solutions model closest to PGHN's mandate business, has a comparable 43% EBIT margin and 32% ROE, and trades at 17x earnings — barely above PGHN.

The big US alts dominate scale, not unit economics. BAM has 23% ROE on USD 1,075bn AuM — three times the FpAuM but half the return on equity, because real-assets dollars carry lower fee margins. Apollo's 22% EBIT margin is depressed by insurance accounting; KKR's headline 4% operating margin is meaningless once Global Atlantic is backed out. PGHN's 60% EBIT and 55% ROE are the cleanest in the cohort precisely because there is no insurance subsidiary.

What good looks like in this peer set:

• A 60%+ EBIT margin (PGHN, BX) signals a genuinely fee-driven, disciplined firm rather than one buying revenue with balance-sheet leverage.
• 30%+ ROE with no insurance subsidiary (PGHN, BAM, HLNE) is hard to fake.
• The ratio of bespoke-and-evergreen AuM to traditional closed-end AuM is the real moat indicator. PGHN's 67/33 is the highest in the listed cohort; BX is moving the same direction with BREIT/BCRED/BXPE.

3. Is This Business Cyclical?

Cyclical at the earnings line, much less so at the management-fee line, barely at all at the AuM line. That separation is the central feature of how to value private-markets GPs.

The total-revenue line zigzags. The management-fee line just climbs. Two cycles illustrate the difference:

2020 COVID year: total revenue fell ~12% as performance fees collapsed 58% (carry crystallizations froze when exits froze). Management fees still grew 2%. EBIT margin held at 62%. Profit fell 13%, not 50%.

2021 mega-cycle: the realization window flew open. Performance fees jumped from CHF 157m to CHF 1.16bn — 7x in one year. Revenue jumped 86% and EPS nearly doubled. Then 2022 brought the mean-reversion: performance fees collapsed 70%, revenue fell 29%, EPS dropped 29%. Anyone capitalizing 2021 earnings discovered the meaning of "ate at the top of the cycle."

2022–2024 fundraising drought: industry-wide fundraising fell ~31% from 2021 peak. PGHN's revenue and EPS held flat-to-mildly-growing the whole way — management fees grew with AuM (USD 127bn at end-2021 to USD 152bn at end-2024 despite the macro), and performance fees normalized to a low base instead of disappearing.

2025 partial reopening: realizations +47%, performance fees +60%, total revenue +20%. CHF appreciation against USD/EUR ate most of the reported management-fee growth (reported +7%; constant-currency +12%).

Performance fees and EPS are cyclical, AuM and management fees are secular. Discounting earnings using the recent five-year average (and not 2021 or 2022 alone) gives a reasonable normalized number — and that is the lens management is formalising by guiding performance income to 25–40% of revenue across cycles.

4. The Metrics That Actually Matter

For PGHN the metrics that decide value creation are AuM growth and its quality, the fee margin, the bespoke share of inflows, the EBIT margin, and the dividend / ROE on a stable equity base.

What is consistent (fee margin, bespoke share, EBIT margin — all stable at "strong") and what is genuinely cyclical (performance-fee mix, AuM growth). The strong+stable rows are the value drivers. The cyclical rows tell you when to buy or trim.

Three additional signals worth watching: (1) gross new client assets vs tail-downs in each half-yearly trading update — the leading indicator for revenue 12–18 months out; (2) wealth-channel inflows as a percentage of fundraising — currently growing but still under-disclosed; and (3) management-fee EBITDA as a separate line (CHF 1,090m in FY25 vs CHF 1,033m in FY24, +6%) — the underlying recurring earnings stripped of cycle effects.

5. What Is This Business Worth?

The right valuation lens is earnings power on a normalized fee mix, plus a residual option on the realization cycle. It is not sum-of-the-parts — the four asset classes share the same employees, same balance sheet, same platform, and PGHN does not list any subsidiary or own a separately-valued insurance business. It is also not P/B — the equity is small (CHF 2.2bn) relative to the franchise value. The cleanest lens is P/E on through-cycle EPS with explicit treatment of the management-fee vs performance-fee mix, cross-checked by dividend yield given the 95% payout ratio.

At year-end 2025 the stock trades on 20.3x trailing earnings, 16.0x EV/EBITDA, and a 4.3% dividend yield — the cheapest end of its decade-long range. Three years ago in the 2022 trough, the same multiples were near-identical (20.9x, 17.2x, 4.1%). The catch in 2025 is that performance fees have already recovered; the cheapness is on a fattened earnings base. Normalize the 32% performance-fee share to a 28% mid-point and the through-cycle multiple is closer to ~22x — still below the 25x 10-year median.

How to underwrite this business:

• Pay for the annuity at a high-quality compounder multiple (high-teens to low-20s P/E) on management-fee EBITDA.
• Add a small option value for performance fees rather than capitalizing the current crystallization rate.
• Treat the dividend yield as a soft floor — at 95% payout and 19 unbroken years of growth, it would take franchise-level deterioration to break.
• Don't try to SOTP — every PGHN dollar of AuM goes through the same platform, the same fee, the same cost base.

The valuation case depends on three conditions: whether AuM compounding to USD 450bn by 2033 is achievable at the current fee margin; whether the wealth-channel partnerships (BlackRock-Morgan Stanley, Deutsche Bank, PGIM, Generali) become meaningful; and whether the management-fee margin holds against platform fee-sharing. If all three hold, the stock is cheap; if institutional fundraising stays muted, wealth channels disappoint, and the management-fee margin slips toward 1.10%, it is not.

6. What I'd Tell a Young Analyst

Watch the management fee, ignore the noise. Performance fees move the print and move the stock — but they are the residual, not the engine. The single most informative line in every half-yearly report is management-fee EBITDA growth. Compound at low double digits and the equity compounds regardless of what carry does in any given year. Drop below high-single digits for two years in a row and the franchise is fading.

The bespoke share is the moat. Track it every report. When mandates+evergreens hold above 70% of inflows, PGHN is winning the "scale plus customization" trade the US giants cannot copy at PGHN's price point. Drift toward 60% means traditional LP fundraising has come back at the expense of the differentiated solutions business — at which point the multiple would deserve to converge toward EQT/Carlyle, not Hamilton Lane/Blackstone.

The wealth-channel narrative is real, but slow. ELTIF 2.0, the BlackRock-Morgan Stanley SMA, the Deutsche Bank evergreen — these are 3–5 year build-outs, not next-quarter catalysts.

The market is most likely missing: that management-fee compounding is more durable than the cyclical headline suggests, and that CHF reporting distorts the underlying USD/EUR growth of the franchise (constant-currency mgmt fees grew 12% in 2025 vs reported 7%). It is most likely over-believing: that the FY2025 32% performance-fee share is the new run-rate.

What would change the thesis: (1) a sustained drop below 60% in the bespoke share of fundraising; (2) a fee-margin slip below 1.15% — wealth-platform partners extracting too much economics; (3) a dividend cut — never cut in 19 public years, so the day it does is the day the moat broke; (4) a CHF break-out vs USD/EUR materially above current levels that compresses reported margins for an extended period; (5) Grizzly-style mark allegations whose substance is not refuted with quarterly external NAV evidence.

The simple takeaway: PGHN is the cleanest, highest-margin, most differentiated mid-sized European listed alt — priced at the cheapest end of its decade. The bull case is the bespoke moat plus wealth channels compounding for a decade. The bear case is that 2025 is the cyclical top and CHF strength masks underlying fee-margin pressure. Track three numbers every six months — management fee growth in constant currency, the bespoke share, and the EBIT margin — and the asset stories that fill the annual report become texture, not signal.

---

Long-Term Thesis — 5-to-10-Year View

1. Long-Term Thesis in One Page

The long-term thesis is that Partners Group compounds fee-paying AuM from USD 185bn today to roughly USD 450bn by 2033 — an 11–12% CAGR — while defending the 1.18–1.33% management-fee margin band it has held for ten years, and that the bespoke-mandate plus evergreen wrapper protects pricing in a way US scale alts and European pure-play peers cannot replicate at PGHN's size. The 5-to-10-year case works only if two things hold: management fees keep compounding at low double digits in constant currency through the wealth-channel build, and the contested Level-3 marks in the evergreen book hold up to repeated exit-versus-NAV tests. If both hold, the combination of a 4.3% dividend yield, mid-to-high-single-digit earnings growth, and any normalisation from today's 20× toward the decade median of ~25× would be consistent with a low-double-digit annualised total return through 2033. PGHN trades at the cheap end of its 15-year range precisely because the bend in FY24/FY25 management-fee growth and the Grizzly Research short report have introduced two real uncertainties; the underwriting question is whether those are cyclical or structural.

---

2. The 5-to-10-Year Underwriting Map

The first two drivers do most of the work. AuM compounding plus a stable management-fee margin is roughly 75% of the long-term return, and both have a decade of supporting evidence behind them. The other five drivers either set the price (driver 3 = the moat that justifies the multiple) or carry the headline risks (drivers 4 and 7 = the credibility and people stories that ended FY25 in front of the market). Driver 5 — wealth-channel monetisation — is the most under-tested historically because PGHN's evergreen book is dwarfed in absolute terms by Blackstone's, and the partnership-led model has not been proven at the USD 100bn-evergreen scale that competitors have already crossed.

---

3. Compounding Path

PGHN's compounding math is the cleanest among listed alts: revenue is roughly management fee margin × average AuM plus a cyclical carry overlay, and operating leverage drops ~60% of incremental management-fee revenue to EBIT. From 2015 to 2025 the platform grew revenue 4.1×, EPS 3.3×, and the dividend 4.9×. The next decade depends on the same arithmetic running on a larger base.

The AuM line shows the shape the next 8 years should follow: step-ups and consolidation periods averaging low double-digit growth. The CHF revenue line wobbles more (performance-fee cyclicality and CHF translation), but the underlying USD revenue line — visible inside constant-currency disclosure — climbs more smoothly. The dividend line is the third confirmation: 19 consecutive raises, 16% CAGR since the 2006 IPO, never cut.

The 2033 row is mechanical, not aspirational. It assumes (i) AuM hits the management-disclosed USD 450bn target at an 11.7% CAGR, (ii) fee margin drifts down 6 bps over 8 years from 1.24% to 1.18% as wealth-channel mix grows (deliberately conservative), (iii) revenue compounds 7% CAGR in reported CHF — slower than AuM because of margin drift and FX — (iv) operating leverage moderates as the firm scales below today's 60% EBIT margin, and (v) the dividend compounds at the same 7% rate management has guided. The end-state is a CHF 5bn revenue, CHF 2.3bn earnings, ~CHF 78 dividend franchise — about 80% larger than today, on a fee base that is recognisably the same business model. On that path, a flat 20× multiple plus the dividend yield would be consistent with a low-double-digit annualised return; a re-rating toward the 25× decade median would lift the IRR into the mid-teens.

Balance-sheet capacity is the constraint to watch. A 95% payout ratio leaves only 5% of earnings to retain — meaning equity grows on the margin only when buybacks recycle below book and when treasury stock is reissued for M&A. PGHN has run with net cash for most of its history and only recently flipped to net debt CHF 485m. The path requires either (a) the payout drifting back to 85% to fund balance-sheet growth, or (b) a tolerance for net debt / EBITDA approaching 1.0× by 2030 if dividends keep growing at 7% while EBITDA grows at 6%.

---

4. Durability and Moat Tests

Tests 1 and 4 are the financial durability anchors — observable in every half-yearly report. Tests 2 and 3 are the competitive durability anchors — they govern whether the multiple stays in the 18-25× band or compresses toward the EQT/Carlyle 15-20× range. Test 5 is the joker: a clean succession is a non-event; a botched one would force a re-underwrite of every other test simultaneously because the people are the asset.

All three lines sit in narrow bands across a decade that included COVID, a zero-rate mega-cycle, a three-year drought, and a reopening. That is the empirical case for durability. The forward question is whether the wealth-channel build is the first regime where one of these three lines bends — and which one bends first will say whether it is a pricing-power loss (fee bps fall first), a mix shift (bespoke share fall first), or a cost discipline failure (EBIT margin fall first).

---

5. Management and Capital Allocation Over a Cycle

The capital-allocation pattern is unusually consistent: distribute almost everything, never dilute, accumulate treasury, lever modestly when the wedge appears. Cumulative FY15-FY25 distributions were CHF 7.3bn dividends plus CHF 3.7bn buybacks against CHF 9.9bn of net income — a 111% payout decade — funded by a structural shift from CHF 1.55bn net cash (FY21) to CHF 485m net debt (FY25). PGHN has never cut the dividend in 19 public years, has not diluted share capital since the 2006 IPO, and has paid 16% CAGR DPS growth across two cycles. For a 5-to-10-year holder this is an income compounder financed by an asset-light fee engine.

The four 5-to-10-year capital-allocation watch items are narrower than that record suggests. First, the payout discipline. FY25 dividend coverage was 87% on EPS but only 73% on FCF after buybacks — meaning the dividend cushion has been thin for three consecutive years. A mid-cycle perf-fee trough could push the headline payout above 100% temporarily, and management has shown willingness to fund the gap with debt rather than cut the dividend. That choice protects the streak but adds rating-agency sensitivity. Second, M&A discipline. PGHN has been organic for 20+ years; the Empira real-estate acquisition (FY24-FY25, intangibles CHF 100m → CHF 365m) is the first material platform deal since IPO. Empira RE marks have been written down -13% and -7% in the two years since acquisition with no impairment yet — a yellow flag, not a structural change. Third, founder alignment. Founders Erni, Gantner and Wietlisbach own ~15% combined, net-bought CHF 33.7m into the March 2026 crash, and have not sold in size since IPO. Best-in-class alignment — caveated only by the IOC veto power that concentrates investment-decision authority on two men into the early 2030s. Fourth, CEO succession. Layton's 2-3 year transition is the single largest people-side risk. The internal-grooming track record (Meister → Layton was successful) and founder multi-decade retention reduce the probability of a mishap, but the window coincides exactly with the wealth-channel scale-up.

The pattern that would worry a long-term holder is the FY23 and FY25 rows — FCF below dividends + buybacks — repeating for two or three consecutive years in a slow vintage. That is the scenario where the capital-allocation framework gets tested.

---

6. Failure Modes

---

7. What To Watch Over Years, Not Just Quarters

These five signals separate the 5-to-10-year thesis from quarterly noise. None of them are answered by a single print; all require a pattern across two or more reporting cycles. A long-term holder watches the constant-currency mgmt-fee compounding rate and the bespoke share of inflows the way a building-products investor watches a peer's pricing-versus-cost spread: a leading indicator that bends 12-24 months before the headline numbers do.

---

Competition — Partners Group Holding AG

Competitive Bottom Line

Partners Group's moat is real but narrow, and concentrated in one product line: the bespoke multi-asset mandate. With 67% of AuM in mandates plus evergreens — by far the highest in the listed-alts cohort — PGHN earns a 60.1% EBIT margin and a 55% ROE on a fee-only, asset-light book that no large peer can match without first stripping out an insurance balance sheet. That edge is genuine but it does not protect the firm on every front. The single competitor that matters most is Blackstone: BX has a five-to-eight-year head start in the wealth channel (BREIT, BCRED, BXPE alone hold more retail evergreen capital than PGHN's entire evergreen book) and is moving fastest where PGHN must grow. EQT and Hamilton Lane are the closer pure-play comparables on economics, but neither sets the strategic tempo for the industry the way Blackstone does.

The Right Peer Set

Five listed peers cover PGHN's competitive surface. EQT and Bridgepoint are the European-listed private-markets pure-plays — the same business model, same fee structure, same LP base. Hamilton Lane is the closest economic match for the 70% of PGHN's AuM that is bespoke solutions (customised portfolios, secondaries, co-investments). Blackstone and KKR are not direct peers on customisation but they set the scale benchmark, the wealth-channel pace, and the M&A premium that the equity market pays for an alternative-asset franchise. The four US giants kept as "supplementary" (APO, ARES, BAM, CG) overlap PGHN on individual asset classes but each has a defining business that PGHN does not: credit/insurance (APO/ARES), real-assets (BAM), or legacy PE-only (CG).

The pure-play European pair (EQT, BPT) and the solutions specialist (HLNE) explain how PGHN's economics compare in a like-for-like cohort. The US scale players explain what PGHN must defend against in the next leg of the industry's evolution.

Market caps as of May 2026 (Yahoo Finance); AuM from latest FY2025 disclosures. Enterprise value shown N/A for BX, KKR, APO, CG — Yahoo's summary EV for these names was missing or inconsistent at the run date (APO's reported EV scraped as negative; CG and BX were blank); debt/cash were not retrieved in this run to compute the figure cleanly, so the EV column is left empty rather than guessed. KKR EBIT margin marked null because consolidated revenue includes Global Atlantic insurance net premiums that distort the gross-margin line (operating margin reads 3.8% on $19.5bn revenue but is not comparable to a pure GP).

PGHN sits in the lower-right quadrant the market typically rewards: highest EBIT margin of any peer, lowest P/E of the group except for Hamilton Lane. EQT trades at 2.7x PGHN's multiple on a margin 24 percentage points lower. The gap to Hamilton Lane is the most telling — both are high-margin asset-light specialists trading at near-identical multiples, and both carry a wealth-channel growth story the market has not paid for yet.

Where The Company Wins

1. Bespoke share — the structural moat

The single most informative competitive number is the share of AuM that sits in tailored mandates and evergreen vehicles rather than traditional closed-end commingled funds. Mandates are individually negotiated contracts (often perpetual, no defined termination); evergreens are open-ended funds where investors can be added continuously. Both are far stickier than closed-end LP funds, where the manager has to re-raise every 4-6 years.

PGHN's 67% bespoke share is matched only by Hamilton Lane (which built its entire business model around it). Among the scale alts, only Blackstone is moving aggressively to close the gap — its retail-channel evergreens (BREIT, BCRED, BXPE) are well-disclosed and growing, but they are still a smaller share of BX's $1.24tn AuM than mandates+evergreens are of PGHN's $185bn. Source: PGHN AR2025 client section and CMD 2026; peer figures triangulated from FY2025 10-K/annual report business descriptions in data/competitors/*/annual_report/.

2. Asset-light economics — no balance-sheet distortion

PGHN's 60.1% EBIT margin and 55% return on equity are the cleanest in the cohort because there is no insurance subsidiary or large balance-sheet investment book to flatter the numbers. The contrast with KKR is the most extreme: KKR's consolidated revenue includes Global Atlantic insurance premiums, which drag reported operating margin to 3.8% even though the GP business is very profitable. Apollo runs the same insurance-funded model via Athene. PGHN's margin is the underlying GP margin; theirs is a blended number that requires segment adjustments to interpret.

PGHN ROE of 55% with no insurance subsidy is genuinely top-of-class. The next-cleanest comps — Hamilton Lane (39%) and BAM (23%) — both run materially lower returns because their fee mixes are weighted toward lower-take-rate products (advisory at HLNE, real-assets at BAM).

3. Realisation execution — share gain in the 2025 reopening

PGHN realised USD 26bn of investments in 2025 (+47% YoY) while the broader industry realisations grew approximately 5% per Preqin (industry data cited in PGHN AR2025). Fundraising followed: PGHN raised USD 26bn in 2025 (+22% YoY) vs industry fundraising down 4% over the same period. Two consecutive years of share-gain in a slow market is the strongest evidence that the bespoke moat translates into commercial outcomes when the cycle turns.

Compare what peers showed in 2025 reported revenue:

PGHN's 20% reported revenue growth (24% constant-currency) puts it in the top half of the cohort, materially ahead of EQT (-1%) and the consolidated US giants distorted by insurance revenue (KKR -11%, APO -1%). Bridgepoint's 47% top-line was off a much smaller base and on a deteriorating margin (net margin fell from 16% to 9%); PGHN held a 49% net margin alongside the growth.

4. Fee-margin stability — the pricing-discipline proof

Across FY2015–FY2025 the PGHN management-fee margin held in a 1.18–1.33% band — through COVID, the 2021 mega-cycle, the 2022–24 drought, and the 2025 reopening. No listed peer can show this stability for a comparable horizon because almost all of them changed business mix materially over the decade (BX added insurance via partnerships, KKR closed Global Atlantic, APO closed Athene, BAM spun out the asset-light entity). Hamilton Lane is the only peer with a comparable pricing-discipline record, and it comes from running a solutions-only book.

The implication is that PGHN's clients pay for the portfolio-construction service, not for individual fund access. That price point is what wealth platforms cannot easily replicate by white-labelling someone else's fund. It is also what is most at risk if the wealth channel eventually demands fee concessions in exchange for distribution.

Where Competitors Are Better

1. Blackstone — wealth-channel scale and infrastructure

Blackstone's retail-aimed evergreen book (BREIT real-estate income trust, BCRED private credit, BXPE private equity) has been built since 2017 and now sits at a scale that PGHN's evergreen platform cannot match in absolute terms. BREIT alone was reported at well over $60bn NAV in BX's FY2025 10-K; BCRED has been the fastest-growing private-credit BDC; BXPE was launched in 2023 as the retail private-equity vehicle. PGHN is launching its own equivalents (PG ENG private equity evergreen, mature credit evergreens), but the comparison is years vs months of distribution build, and dozens vs handfuls of wirehouse selling agreements.

Source: BX FY2025 10-K business description (data/competitors/BX/annual_report/FY2025/business.txt). The reader should treat BX's wealth platform as a structural advantage that money cannot quickly close.

2. Apollo / KKR — insurance permanent capital

Apollo's merger with Athene and KKR's acquisition of Global Atlantic gave both firms hundreds of billions of dollars of permanent fee-paying capital that doesn't have to be re-raised. The capital comes from insurance liabilities that the firms manage at private-market spreads — a structurally cheaper distribution channel than fundraising. PGHN's asset-light pure-GP model is, by design, the opposite — every dollar of AuM is client commitment that has to be won and re-won. In a slow institutional vintage, insurance balance sheets keep growing while LP fundraising falls.

Source: APO FY2025 10-K (data/competitors/APO/annual_report/FY2025/business.txt) and KKR FY2025 10-K (data/competitors/KKR/annual_report/FY2025/business.txt). The cost: BX and KKR's reported operating margins are unrepresentative because of insurance accounting, but the AuM compounds without traditional fundraising friction.

3. Pure scale — BX, KKR, BAM on "core platform" RFPs

A pension or sovereign wealth fund reviewing its private-markets allocation for the next five years will typically run a "core platform" RFP — a multi-billion-dollar commitment over multiple strategies to a single GP. The list of GPs invited to that RFP is short and dominated by the firms with $500bn+ in AuM and a complete product shelf. PGHN at $185bn AuM makes that list often (the firm has called out share-gain to "concentrating LP commitments"), but the firms on the list every time are BX, KKR, BAM and the big private GPs (Bain, CVC, Permira). At 6-8x smaller by AuM than the largest scale players, PGHN trades off "always invited" for "differentiated when invited."

4. EQT — pricing power on European mid-market PE

EQT raised the EQT X flagship buyout fund at €22bn in 2023 and the EQT XI is expected to scale further. In the European mid-market PE pool where PGHN deploys roughly a quarter of its PE AuM, EQT is the share leader by deal volume and by LP wallet, and competes on most of the same deals. EQT's brand in the German/Nordic LP universe is the strongest, and recent EQT vintages have published strong realised IRRs (the FY2024 +29% net income jump and FY2025 36% EBIT margin came from accelerated PE realisations).

The implication for PGHN: in the highest-overlap product area, the head-to-head share competition is roughly even, and PGHN does not have meaningful pricing power vs EQT on closed-end PE funds. The pricing power lives in mandate/evergreen architecture, not in fund-level fees.

Threat Map

Moat Watchpoints

The five signals below are the measurable evidence an investor should track every six months. Each is observable in PGHN's interim/annual reporting or in peer disclosure, and each has a clear direction that signals moat improvement or moat erosion.

The hierarchy among these five: #1 (bespoke share) and #2 (fee margin) are the dominant moat-integrity signals — both move slowly but a sustained move in either direction would re-rate the equity. #3 (wealth-channel disclosure) is the most under-priced near-term catalyst — PGHN currently bundles the wealth narrative qualitatively, and any move to disclose a discrete wealth-channel AuM line item with growth would clarify the bull case. #4 (realisations) and #5 (NAM share) are cycle and execution markers — useful for confirming the trajectory, but they do not in themselves prove the moat.

---

Current Setup & Catalysts

1. Current Setup in One Page

The stock is at CHF 858.80, ~9% above the 52-week low of CHF 785 and 27% below where it was a year ago, after a six-month sequence in which a record FY25 print (10 Mar 2026) became a 37% one-day collapse, a co-founder pre-announced David Layton's CEO exit (30 Mar 2026), and Grizzly Research published a 100+ page short report on the evergreen marks (29 Apr 2026). The setup is mixed-to-bearish: the operating engine still printed +20% revenue / +19% EBITDA / +12% profit and the 17th consecutive dividend raise (CHF 46) cleared the 20 May 2026 AGM, yet the multiple has been re-rated to 17.7× trailing P/E because the market is no longer underwriting the wealth-channel build, the Master Fund marks, and the succession overlap as separate problems. The near-term calendar is light but decision-relevant: the next dated catalyst — Master Fund FY-March-2026 N-CSR audit opinion from PwC, due on prior-year pattern in late May / early June 2026 — could either reinforce or weaken the Grizzly thesis before any other reporting cycle runs. The first true thesis-update event is the 15 July 2026 H1-2026 AuM print + outlook, with the heavier September interim sitting just outside the 90-day window. This is the bridge tab: the long-term thesis is intact, the near-term debate is about credibility, and the next 90 days do not decide it but materially compress the range.

---

2. What Changed in the Last 3-6 Months

The recent record has been a sequence of distinct shocks, not a slow drift. Each event was material on its own terms and the market has not yet reconciled them. The table covers events that still control today's setup.

The narrative arc. Six months ago the debate was a quality-versus-multiple debate: PGHN's 60% EBIT margin, 55% ROE and 67% bespoke share were the cleanest in listed alts, trading at the cheapest multiple in a decade. The 10 March guide cut shifted that to a growth-on-an-elevated-base debate (was 2025 cycle-fattened?), the 30 March succession leak added a people-overlap dimension, and the 29 April Grizzly report converted both into a trust debate (do the marks even support the headline EPS?). What investors used to argue about (multiple discount versus moat) has been pushed aside by what they now argue about (Level-3 marks honesty, fee-margin defence under wealth-channel mix, and whether the CEO who built the wealth strategy will be there to execute it). The unresolved questions are the three that the next two disclosure cycles can actually answer.

---

3. What the Market Is Watching Now

Items 1 and 2 are the binary items — they can be settled by a single H1 reporting cycle. Item 3 is the bend-vs-no-bend item that needs a pattern of two halves to update. Items 4 and 5 are process items that quietly move the multiple over the next 12-18 months even if they never produce a headline. The market is watching all five at once because none of them are independent — a soft mgmt-fee print into a soft AuM print into a vague exit-proceeds disclosure is the bear-case correlation that the CHF 785 52-week low is meant to discount.

---

4. Ranked Catalyst Timeline

The ranking is by decision value, not chronology. Item 2 (Master Fund N-CSR) is the highest-leverage dated event because PwC's auditor opinion is a third-party read that lands before any company-controlled disclosure cycle. Item 1 (H1 AuM announcement) is the first event where PGHN itself can answer two of the live questions (flows, exit proceeds) in one release. Items 3 and 6 are the structural reset points — H1 interim and the next FY print + CMD. Items 4 and 5 are wealth-channel and AuM-trajectory items that update the long-term-thesis driver 1 and driver 5. The continuous items (7-9) are not dated but compound the headline catalysts.

---

5. Impact Matrix

The matrix below filters the catalyst timeline down to the items that actually resolve the debate, not the ones that merely add information. The duration-relevance column says whether the catalyst updates the 5-to-10-year thesis or the near-term evidence path or both.

---

6. Next 90 Days

The next 90 days (through ~22 Aug 2026) contain three dated items and two open windows. Notably, the September interim — the single highest-information event in the calendar — falls just outside the 90-day window by ~9 days, which is why the 15 July AuM print is the practical pivot for the quarter.

---

7. What Would Change the View

Three observable signals would most change the investment debate over the next six months, and they map onto the long-term thesis variables the upstream work already identified. First, an unqualified PwC opinion on the Master Fund FY-March-2026 N-CSR (late May / early Jun 2026) with no fair-value KAM emphasis paragraph, combined with a 15 July AuM print showing constant-currency management-fee growth above 7% and at least flat evergreen net flows — that combination would weaken the credibility-cascade narrative and is the precondition for closing the 17× → 22× multiple gap. Second, any single one of: a Level-3 markdown on a Grizzly-named position; a FINMA, SEC or BaFin inquiry; a Master Fund gating event; or constant-currency mgmt-fee growth printing below 7% for a second consecutive half — any of those would break the fee-margin annuity claim (driver 2) or the mark-credibility claim (driver 4) anchoring the bull case, with a re-rating toward the EQT/Carlyle 15-20× band consistent with the Bear tab framework. Third, an external CEO succession announcement or an unexpected senior departure (Jenkner, Gröflin, Marquardt) would force a simultaneous re-underwriting of the wealth-channel build (driver 5) and the founder-alignment story (driver 7) — not because any single departure is catastrophic, but because the timing overlaps so closely with the AuM-to-450bn execution. None of these signals is a single-print binary; the Master Fund N-CSR and the H1 AuM are the first two prints that compress the range, and the 1 September interim is the one that decides which way the next six months actually trade.

---

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the operating record (60% EBIT margin, 19-year unbroken dividend raise, fee margin in a 118–133 bps band for ten years, founders net buying CHF 33.7m into the drawdown) outweighs the bear's mark-credibility critique on weight of disclosed evidence, but the single decisive variable — whether Grizzly's evergreen mark allegations survive the H1 2026 interim disclosure in September — is unresolved and outside the public record today. Bull and Bear agree, almost word for word, that the September 2026 interim print is the test: three named exits (Apex Logistics, STADA, atNorth) clearing at or above mark, plus mgmt-fee constant-currency growth, decides the moat. The tension that matters is mark credibility under Level-3 judgement: PGHN has rebutted scope and named exits, not the position-by-position markup math. Until that test runs, sizing the position requires accepting that the strongest piece of falsifying evidence — the H1 disclosure — is three months out and binary. The conditions that would force a verdict change are below in the ledger.

Bull Case

Bull target & timeline. CHF 1,200 (~45% total return from CHF 859 including the CHF 46+ dividend), built on 22x normalized FY26 EPS of ~CHF 51 — below the 5-year median 27x and well below the EQT/BX cohort 30-40x. Timeline 12-18 months, anchored to the September 2026 H1 interim disclosure and the FY26 print in March 2027. Disconfirming signal: two consecutive halves of constant-currency mgmt-fee growth below 7%, or any flagship evergreen exit at a material discount to last reported NAV, or the mgmt-fee margin slipping below 115 bps.

Bear Case

Bear target & trigger. CHF 650 (–24% from CHF 858.80 spot; –17% below the CHF 785 52-week low), built on 15x trailing P/E on a normalized EPS of CHF 43 — pricing the bespoke premium to compress toward the EQT/Carlyle band and Hamilton Lane (16.8x) becoming the de facto ceiling. Timeline 12-18 months across the September 2026 interim and the March 2027 FY26 print. Cover signal: H1 interim confirms all three contested exits at or above mark and mgmt-fee constant-currency growth above 10% YoY and a discrete wealth-channel AuM line disclosed and growing >25% YoY.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight today because the falsifiable claims on his side — fee margin held in a 118–133 bps band for ten years, dividends raised every year for nineteen, FCF exceeded net income in FY25, and founders with mark access bought CHF 33.7m at a 12:1 ratio into the drawdown — are already in the record, while the bear's strongest claim still lives in a 100-page short PDF that PGHN partially rebutted and a regulator has not endorsed. The decisive tension is mark credibility on the Grizzly-named evergreen positions: PGHN answered scope and three exit names but not the position-by-position issuer-mark math, and 67% of AuM sits in vehicles where that math has to hold. The bear could still be right because Level-3 marks are auditor-blessed not transaction-tested, the FY26 guide reset is the first crack in a decade-long fee-growth record, and a 95–111% payout funded by debt issuance has no cushion if performance fees mean-revert as they did 2021→2023. The durable thesis breaker is the mgmt-fee margin slipping below 115 bps or a confirmed below-mark evergreen exit — either would invalidate the moat that anchors the entire bull case. The near-term evidence marker is narrower and dated: the H1 2026 interim disclosure in early September 2026 with (i) Apex Logistics, STADA, atNorth realised proceeds vs last reported NAV and (ii) constant-currency mgmt-fee growth. Three exits at or above mark plus mgmt-fee cc growth above 7% would support a confirmed Lean Long with the bull's CHF 1,200 framework as the working target; any contested exit below mark or cc growth below 7% would warrant a downgrade to Avoid and put the bear's CHF 650 framework in play as the operative anchor.

---

What, if Anything, Protects This Business

Verdict — narrow moat. Partners Group has a real, observable advantage in one corner of the alternatives industry: building bespoke private-markets portfolios for large institutions and (increasingly) wealth platforms, and earning a 124-bps management fee on capital that, on average, stays for a very long time. Two pieces of evidence make the advantage credible: (i) 67% of AuM sits in mandates and evergreen vehicles versus roughly 30–40% at most listed peers, and (ii) the management-fee margin has held inside a 1.18–1.33% band for ten years across COVID, the 2021 mega-cycle, the 2022–24 fundraising drought, and the 2025 reopening. Those two numbers do not exist together at any other listed alt outside Hamilton Lane. The advantage is also visible in the fee-only, no-insurance return profile — 60.1% EBIT margin and ~55% return on equity — that no scale alt with an insurance balance sheet can reproduce on a clean basis. But the moat is narrow, not wide. It does not cover Partners Group on the next leg of the industry's growth (retail wealth at scale), where Blackstone is years ahead; it has not been stress-tested through a full evergreen redemption-and-mark cycle (the April-2026 Grizzly short report attacked exactly this surface); and the European mid-market PE pool where ~25% of PGHN deploys is openly contested with EQT, Bridgepoint, CVC and Permira. The strongest source — bespoke-mandate stickiness — protects the annuity (management fees on existing book), not the growth (winning the next decade of new flows).

How to read this page. "Moat" means a company-specific economic advantage that protects returns better than competitors. Good execution, an attractive industry, or a popular brand are not moats unless they show up as pricing power, retention, share, or cost. The test below is whether each claimed Partners Group edge passes that bar.

---

1. Sources of Advantage

Six categories of advantage are commonly available to alternatives managers; the table below maps each to whether Partners Group actually has it, what the economic mechanism is, and how strong the proof is. Definitions: switching costs mean clients face cost, risk, retraining, data migration, or operational disruption if they move; scale economies mean unit costs fall as AuM rises; intangible assets include brand, track record, regulated licenses, and proprietary data; network effects would mean each new client makes the platform more valuable to existing clients.

The five rows worth dwelling on are #1, #2, #3, #4 and #5. The first three (switching costs, pricing power, lockup) all draw evidence from the same underlying fact: mandate clients sign multi-year contracts that integrate Partners Group into their portfolio plumbing. That is one moat being measured three different ways, not three independent moats. The fourth (asset-light economics) is partly a style choice — Apollo and KKR consciously chose insurance, Partners Group chose not to — so it functions as an advantage on financial reporting but a disadvantage on capital permanence. The fifth (track record) is the column most exposed to the Grizzly report and is the brand-side proof that needs to be re-validated each year.

---

2. Evidence the Moat Works

For a moat to count, it must show up in numbers. The ledger below collects the seven strongest pieces of evidence in PGHN's disclosure that the claimed advantage is real, and the one or two that argue against it.

The fee-margin stability chart below is the single most informative moat picture. The y-axis (basis points of average AuM) has barely moved in a decade despite five distinct cycle regimes.

---

3. Where the Moat Is Weak or Unproven

Five soft spots are worth naming directly. None invalidate the narrow-moat conclusion, but each one is a reason it is narrow rather than wide.

---

4. Moat vs Competitors

The peer-by-peer view below uses the same set as the Competition tab. The four columns of interest are: (i) what kind of moat the peer relies on, (ii) what evidence supports it, (iii) where they are stronger than PGHN, and (iv) where PGHN is stronger than them.

PGHN and Hamilton Lane sit alone in the >65% bespoke-share bracket. The next-closest peer is Blackstone at ~50%, and only because BX has aggressively grown BREIT/BCRED/BXPE since 2017. The European-listed pure-plays (EQT, BPT) and the legacy US PE manager (CG) are still predominantly closed-end. The closer comp on moat type is Hamilton Lane; the closer comp on scale is Blackstone. The interesting commercial question is whether PGHN can keep the HLNE-style moat while approaching BX-style scale in wealth distribution.

---

5. Durability Under Stress

A narrow moat only matters if it survives stress. The five stress cases below are the realistic 24–36 month tests PGHN faces; each is mapped to historical precedent and a signal to monitor.

The pattern is clean: the moat holds up well against cyclical stress (recession, drought), survives single-stressor regulatory shifts, and degrades only under a combined stress — wealth-channel fee compression plus a marks-credibility event plus mgmt-fee growth bend. That combination is not in evidence today, but each individual component is being tested.

---

6. Where Partners Group Holding AG Fits

The advantage does not live equally in every part of the franchise. To make underwriting decisions you have to know which segment carries the moat and which is commodity.

The way to think about Partners Group: the firm is one franchise with one platform, but the moat is concentrated in one product line (bespoke mandates) and partially in another (evergreens). The closed-end PE, private-credit, and real-asset segments are participations in an industry — attractive in absolute terms but not the moat. This is exactly why the Business tab notes that SOTP is the wrong lens: the segments share the same employees and platform, but the moat lives in the wrapper, not in the underlying asset classes.

---

7. What to Watch

The watchlist below is the six-month dashboard. Each signal is observable in PGHN interim/annual reporting or in cross-listed peer disclosure; each has a defined "better" and "worse" threshold so an investor can update the moat read mechanically rather than impressionistically.

---

The Forensic Verdict

Forensic Risk Score: 52 / 100 — Elevated. The audited Group-level financials look broadly defensible — five-year operating cash flow converts net income at 0.83x, performance fees are constrained by a 50% NAV write-down test, and the auditor transition from KPMG to PwC was disclosed and orderly. The risk is one level up the stack: the fair-value marks inside Partners Group's flagship evergreen funds (notably the US-registered Master Fund) were publicly challenged by Grizzly Research on 29 April 2026, the same year management is early-adopting IFRS 18 and rolling its first-ever net redemptions in the Master Fund. The top two concerns are (1) Level-3 valuation discipline in the evergreen vehicles that drive ~25% of group performance fees, and (2) a high-payout, debt-funded capital return policy that leaves only a thin cushion if performance fees compress. The single data point that would most change the grade is the realized exit price of the contested positions (Apex Logistics, STADA, atNorth) versus their last reported marks — management says all three exited above mark in Q4 2025 / Q1 2026, and the FY2026 interim disclosures will be verifiable.

Shenanigans scorecard

The two red flags both center on classification choices that obscure year-over-year comparability rather than on fabricated transactions: the optional grouping of short-term inter-fund loans inside operating activity, and the early adoption of IFRS 18 that resequences the income statement at the same time evergreen flows are under scrutiny. The Wirecard comparison made in the Grizzly report is rhetorical — the underlying allegation is that Level-3 marks were optimistic, not that revenue was fabricated.

Breeding Ground

Founder-dominated board with disciplined disclosure, but a 95% payout culture and high-conviction equity story make beat-and-raise pressure structural. Three of the four executive directors (Erni, Gantner, Wietlisbach) are the 1996 founders who each individually disclose ~5% holdings on SIX. Chairman Steffen Meister rejoined the Board in 2013 after a prior 2001-2005 stint and was CEO until 2023. The independent count is four out of eight (Angehrn, Lester, Olivier, Zhao), with Gaëlle Olivier as Lead Independent Director and Risk & Audit Committee Chair.

The structural amplifier is incentive design: up to 40% of performance fees are allocated to employees, so personnel cost moves mechanically with the same NAV-stress and write-down judgments that determine revenue. That is industry-normal for alternatives but means any optimism inside the Level-3 valuation models cascades into both lines simultaneously. The dampener is auditor independence: PwC has just inherited the audit after a competitive tender that began in 2022 — a fresh second set of eyes is in place exactly during the Grizzly debate.

Earnings Quality

Reported revenue and earnings convert to cash in the long run, but the receivables ramp and the FY24 DSO blow-out are worth underwriting. Group revenue grew from CHF 1,944M (FY23) to CHF 2,563M (FY25), driven by a 60% jump in performance fees to CHF 819M in FY25. Performance fees are recognized only when realized investments clear a hurdle AND the remaining NAV passes a 50% stress test — a relatively conservative claw-back framework. The income statement test that mattered most: receivables expanded faster than revenue in four of the last nine years, with FY24 the worst gap (AR +41% vs revenue +10%).

The FY24 gap (+31pp of receivables outgrowing revenue) almost certainly reflects accrued performance fees that hadn't yet hit cash — performance fees jumped to CHF 511M that year, much of it tied to portfolio realizations that take quarters to settle. FY25 mostly normalized DSO back to 162 days, with cash collection broadly catching up. The pattern is consistent with sector accounting, not with channel stuffing, but DSO above 150 days is a number a PM should keep watching.

The five-year EBITDA-margin band of 62.6%-64.3% is unusually narrow for a business in which 24-32% of revenue is performance fees. Smoothness is not evidence of manipulation, but it is the kind of pattern that earns a yellow flag in a forensic checklist — the firm's stated 50% stress-test discount on unrealized NAV is what mechanically tames the volatility. Net margin grinding down from 60% (FY17) to 49% (FY25) reflects rising tax (11%→18% as Pillar Two adopted in 2024) and higher interest cost rather than operating decay.

Intangibles tripled in FY25 from CHF 100M to CHF 365M. This reflects the Empira Group acquisition (Swiss real-estate manager closed in 2024-2025) and the CHF 95M acquisition outflow in FY25 cash flow. PP&E plateaued at CHF 506M after the new Baar-Zug campus and the Denver campus completed — the FY25 D&A bump of +43% to CHF 69M is consistent with the campus depreciation plus newly-recognized Empira customer-contract intangibles. None of these items were classified as "non-recurring".

Cash Flow Quality

Cash conversion looks healthy on a five-year stack but is volatile year-to-year and is buffered by a CHF 9.5B gross debt-issuance carousel. Net income converted 0.91x to operating cash flow over three years and 0.83x over five years — within tolerance for a business that warehouses bridge loans on the balance sheet on behalf of clients.

The years where CFO undershot net income materially — FY18 (0.37x), FY21 (0.48x), FY23 (0.64x) — coincide with peak performance-fee recognition where the accrual hits the income statement years before cash arrives. That is a feature of the model, not evidence of distortion. The risk is mix shift: as evergreens (~30% of AuM) take share from closed-ended traditional programs (~33%), the cash-timing of performance income changes. Evergreens charge perf fees quarterly on NAV development above a high-water mark — converting accrued perf fee to cash depends on continued positive NAV development AND on investors not redeeming.

The capex collapse from CHF 114M (FY24) to CHF 9M (FY25) is the kind of single-year drop that triggers a forensic flag, but the disclosed driver is the completion of the Baar-Zug and Denver campus build-outs — there is no parallel surge in capitalized "other assets". Confirmation will come when FY2026 capex returns to a steady-state CHF 30-50M range. If FY26 capex stays at FY25 levels, this becomes a yellow flag.

FCF has not covered dividends + buybacks in any year since FY21. The shortfall is plugged by net debt issuance — CHF 270M in FY22, CHF 300M in FY23, CHF 674M in FY24, CHF 354M in FY25. Gross debt issuance in FY25 was CHF 9,550M with repayments of CHF 9,196M; that volume reflects PG's treasury-management bridge loan business that nets out, but the ratio of cash returns to underlying earnings has run at 95-97% of EPS for two consecutive years per management disclosure, with the gap to FCF widening in years of heavy performance-fee accrual. This is not a cash-flow shenanigan; it is a capital-structure choice that increases sensitivity to a performance-fee compression year.

Metric Hygiene

The most consequential metric debate is what counts as "evergreen revenue", and management is changing the income statement's top line just as that debate intensifies. Grizzly's report led with "evergreen funds contribute almost half the company's revenues"; PG's same-day rebuttal called the actual figure 34%. The AR2025 disclosure: evergreens are 30% of AuM (page 24); performance fees were 32% of total revenues in 2025, of which evergreens contributed 25% (so evergreens ≈ 8% of total revenue from perf fees, plus their share of the 68% management-fee bucket weighted to ~30% AuM share — directionally between PG's and Grizzly's numbers).

The IFRS 18 early adoption is the single biggest metric-hygiene watch-item. From 2026, performance fees and investment income (Level-3 fair-value changes on PG's balance-sheet co-investments) will be presented together as "performance income" with a guided 25-40% of total revenues. That mechanically pulls fair-value movements on the firm's own NAV out of "finance result" (where they were CHF 75M in FY25) and into the operating top line. The change is IFRS-mandated by 2027 and is technically required for all companies, but the early adoption decision and the combined disclosure are choices. The investor who wants the old comparability will need to track the company's reconciliation table.

The FY24 DSO of 197 days is the receivable-quality figure that should drop into a quarterly tracker. It cleaned up by 35 days in FY25 — consistent with realizations converting to cash — but if it climbs back above 180 days at any quarter-end, the model is telling you that accrued performance fees are running ahead of realized cash collection.

What to Underwrite Next

Five items to track between now and the FY2026 interim report (typically published early September 2026):

1. Realized exit prices of the three positions Partners Group named in its 30 April 2026 rebuttal — Apex Logistics (Zenith Longitude vehicle), STADA Arzneimittel AG (Ciddan vehicle), atNorth (Green DC Lux Co). Management stated all three exited above their last reported marks in Q4 2025 or Q1 2026. The H1 2026 NAV report and Master Fund SEC schedule (N-CSRS) will show the proceeds. If proceeds confirm marks, the Grizzly thesis weakens materially.

2. Master Fund net flows for Q1-Q2 2026. Grizzly noted the Master Fund hit its first-ever annual net redemptions in 2025 with Q3 2025 redemption requests of US$750M (double the prior year). Management has guided gross client inflows of US$26-32B for full-year 2026 against US$2.8B invested in Q1 vs US$5.7B returned. If gross inflows materially miss CHF-equivalent guidance, perf-fee accrual on evergreens compresses immediately.

3. First IFRS 18 restated income statement — comparison of FY2025 numbers under both IFRS 18 ("performance income") and IFRS 15 (legacy presentation). The reconciliation table should show the magnitude of the reclassification and whether any prior-period adjustments come along.

4. PwC first-cycle key audit matters (KAMs). PG's prior auditor KPMG had this audit since at least 2008. PwC's FY2025 audit opinion was issued (filing dated 10 March 2026) — the wording and number of KAMs around fair-value measurement of unquoted investments and performance-fee recognition is the most direct external read on Level-3 valuation discipline.

5. DSO trajectory through Q2 and Q4 2026. A drop below 130 days would corroborate that the FY24 spike was working capital, not earnings quality. A re-acceleration above 180 days would suggest the perf-fee accrual is outrunning cash collection.

Signal that would downgrade the grade to "Watch" (21-40): All three contested exits land at or above last-published mark with disclosed proceeds; H1 2026 evergreen net flows positive; PwC clean opinion with no fair-value KAM emphasis paragraph; IFRS 18 reconciliation matches consensus.

Signal that would upgrade the grade to "High" (61-80): Any exit lands below mark with a meaningful write-down; FINMA or SEC opens an inquiry; PwC's opinion adds an emphasis-of-matter paragraph on fair value; evergreens enter gated redemption status (gating provision in AR is 20-25% of NAV per year, stricter possible for up to two years).

Position-sizing implication. This is not a thesis-breaker for an institutional reader who already underwrites alternatives at Level-3 discount, but it is a margin-of-safety adjuster. Until the three contested exits are confirmed at or above mark, an underwriter should haircut performance-fee NAV in their valuation model by an extra 10-15% on the evergreen book specifically and treat the FY25 dividend coverage of 95% of EPS as the policy ceiling, not the policy floor. The forensic work belongs in the position-sizing limiter column — not the valuation-haircut column for the management-fee EBITDA, and not the thesis-breaker column. If the H1 2026 reporting confirms management's account, the grade should fall back to Watch within twelve months.

---

The People

Governance grade: B. The three founders still hold ~15% of the equity 30 years in, the comp framework actually penalises bad years (LTI pool was cut 4% in 2025), and there are no golden parachutes or outstanding loans — but the founders also wield veto power over every investment decision and quietly extracted CHF 15.3 million of waived management/performance fees in 2025 alongside their listed compensation, which is the real alignment story.

1. The People Running This Company

Four executives — the Executive Chairman and the three 1996 co-founders — sit on the Board alongside four independents. The CEO (David Layton) is American, runs the firm from Denver, and is the only Executive Team member with truly significant equity at risk; the rest of the ExTeam owns trivial amounts. The founders are the gravitational centre.

Trust the capability, watch the concentration. Layton was promoted from Head of Private Equity — a deal guy, not a generalist CEO from outside — and the founders coached him for years before handing him the title. That continuity is a strength. The risk is that strategy is still effectively set by four men who have been in the room together since 1996, and the independents (all added 2022 or later) are recent additions stress-testing decades-old habits. Succession is functional at the CEO seat but unproven for the founder seats, where Gantner, Erni and Wietlisbach are all 56–64 and central to investment oversight.

One genuine governance upgrade: Dr. Urban Angehrn (ex-FINMA CEO, ex-Zurich CIO) joining in May 2025 brings real regulatory teeth onto the Risk & Audit Committee, just as the Grizzly Research short report (Oct/Nov 2025) attacked Partners Group's evergreen-fund NAV marks. The timing is helpful for credibility.

2. What They Get Paid

Total awarded pay for the 10-person Executive Team was CHF 67.4 million in 2025 (down from CHF 69.7M in 2024); the eight-person Board was awarded CHF 13.6 million before related-party benefits, and CHF 28.95 million including waived ECP fees. CEO David Layton received CHF 15.93 million awarded and CHF 10.01 million realized.

Pay is sensible — with one caveat. Layton's CHF 1.66M cash base + deferred is below the median of US listed alternative managers (Blackstone, KKR, Apollo, Ares CEOs all clear USD 10M+ in base+bonus). The reason awarded total rises to CHF 15.9M is the ExMCP performance-fee LTI: it is capped at 1.20x grant, payouts only flow if portfolios clear pre-agreed return hurdles, and the firm explicitly funds it from the unallocated portion of the 40% carry pool — so the framework claim of "no additional cost to shareholders" is defensible if you accept that the 40% pool was always at risk of being allocated elsewhere in the firm. Realized 2025 of CHF 10.0M is what actually moved between accounts; the ExMCP grant is a vintage call option on 2025 deals that will or will not pay in the early 2030s.

The LTI pool was cut 4% in 2025 because the quantitative component (Mgmt Fee EBITDA growth) came in below target at 0.69x. That is pay-for-performance actually working, and a tangible response to the rougher fundraising environment.

Sarah Brewer and Andreas Knecht stepped down from the ExTeam on 1 January 2026 but remain in senior roles; Ana Campos (HR) and Anette Waygood (Co-Head Compliance & Legal) joined. The firm has committed to a three-year freeze on total base compensation alongside the new ExMCP carry program.

3. Are They Aligned?

This is where Partners Group is genuinely different from public-markets asset managers and genuinely complicated.

Ownership and control. The three founders collectively own about 15% (4.04 million shares of 26.7 million) — and with Executive Chairman Meister's stake the four-person executive Board controls roughly 16.5% of the equity. Per the latest CGR they have held substantially the same positions through 2025 (Erni +1,930 shares; Gantner +1,930; Wietlisbach +1,930). There has been essentially zero net insider selling in 2025. Combined with the fact that Partners Group has not diluted its share capital once since the 2006 IPO (LTI is settled from treasury), this is best-in-class alignment for a listed asset manager.

Capital allocation. The firm runs a deliberately lean balance sheet — bonds are CHF 1.33B outstanding (June 2019, Sep 2023, June 2024 issuances) and management invests treasury into a buyback-style accumulation rather than aggressive expansion. Treasury is now 3.43% of shares.

Insider buying vs. selling — Switzerland constraint. Swiss-listed PGHN does not file Form-4-style trades; significant-shareholder disclosures only update when crossings happen. The founders' aggregate positions have been static-to-slightly-rising for years, and they only trade in the two annual Order Windows that follow earnings.

Related-party behaviour — this is the alignment friction. Partners Group runs an Employee Commitment Plan (ECP) under which executives and Board members invest alongside clients on fee-waived terms. The 2025 waived fees disclosed to the Board are large:

That is CHF 15.3 million of effectively additional Board compensation that does not appear in the headline pay table — it is fee revenue the firm did not collect from the founders' co-investments. It is disclosed and shareholder-approved, and the founders' co-investments do align them with client returns; but it materially understates true Board take-home and is the single biggest related-party item in the filings.

Founder veto over investment. Per the CGR, IOC members Erni and Gantner together hold one vote in the Global Investment Committee and have the right to veto any GIC transaction. Two men can stop any investment the firm wants to make. For a private-markets manager whose only product is judgement on deals, that is a meaningful concentration of decision power 20+ years after they stepped out of CIO roles. It is also what allows them to dedicate 2–3 days a week (not full-time) and run outside ventures: Gantner chairs Breitling, PG3, Real North, Community Climate Solutions; Wietlisbach chairs Blue Earth Capital, WieRe, Power Source Holding.

Skin-in-the-game score: 9/10. Founders own ~15% after 30 years, no dilution since IPO, mandatory shareholding (CEO 6x base, ET 3x base) is enforced (6 of 10 currently compliant, the two non-compliant are 2024 joiners with 5 years to comply), realized pay tracks shareholder outcomes (cut from 14.3M to 10.0M last year), and there are no severance / golden-parachute / change-of-control accelerants. One point off only because the IOC veto + ECP fee waivers means founders extract some value that arms-length shareholders cannot.

4. Board Quality

Eight members; four executive (Meister + three founders); four independent (Angehrn, Lester, Olivier, Zhao). Lead Independent Director: Gaëlle Olivier, who also chairs RAC and OOC. On paper this is best-practice 50/50. In practice the executives chair every operationally important committee (IOC, COC) and the independents are concentrated on audit, comp and risk oversight.

The real independence question. All four independents are credible: Olivier ran AXA's P&C globally and was Deputy GM of Société Générale; Angehrn ran FINMA and was Zurich's CIO; Lester ran JPMorgan AM Retirement Solutions for 30 years; Zhao ran BP Gas Asia and is currently a Temasek Senior Advisor. None has prior PG line management; none has line-management functions today; tenures are short (1–4 years), so capture risk is low. The weakness is not the individuals — it is that they sit on RAC/NCC/OOC while the founders own IOC and COC. The committees that decide what the firm invests in are executive-controlled; the committees that decide whether the firm is run honestly are independent-controlled. That is a defensible split for a private markets manager, but it leaves the Grizzly-style "are these marks honest?" debate to executive-controlled IOC plus the new ex-FINMA member on RAC.

Process quality is high. 2025 aggregate Board attendance 90%; five Board meetings; RAC met five times with PwC present; auditor was rotated from KPMG to PwC in May 2025 after a clean tender (KPMG was lead auditor for many years). No outstanding loans to any Board or ExTeam member. No change-of-control / golden parachute provisions. The bonus-malus / clawback right exists and has never been used. 87% shareholder approval of 2024 comp report — high but not unanimous.

Composition trend is positive. Three of four independents are women; Olivier, Angehrn, Lester and Zhao represent French, Swiss, American and Singaporean nationalities. The Board target of 50% under-represented groups in new independent appointments (3-year rolling) is being met.

Best descriptor: real independence on audit/comp, executive control on investment. Functional, not captured, but the founders' veto block keeps it from being fully arms-length on the decisions that matter most to a private-markets manager.

5. The Verdict

Grade: B. This is a well-governed private-markets manager by the standards of its peer group, with genuine founder skin-in-the-game and a pay framework that actually flexes with performance — but a few structural features keep it from an A.

What would move the grade.

Upgrade trigger (B → A−): the firm voluntarily caps or eliminates ECP waived fees for Board members, or a credible independent valuation review of evergreen-fund NAVs is commissioned and published in response to the short-seller report, or an independent director is added to the IOC with veto rights.

Downgrade trigger (B → C): material confirmation of any of the Grizzly NAV-markup allegations, or a related-party transaction emerges that has not been pre-disclosed under the ECP, or the founders' outside ventures (PG3, Real North) develop financial entanglements with PG portfolio companies that look like related-party deals.

For now, the answer to the question "do management and governance deserve trust?" is yes, with eyes open. The founders have earned the benefit of the doubt on integrity through 30 years of zero dilution and substantial personal ownership. They are also extracting more economic value than the headline tables suggest, and the institutional infrastructure to challenge their investment decisions does not yet exist inside the Board.

---

The story Partners Group has been telling

For most of the five years through 2025, Partners Group's story barely changed: transformational investing, thematic sourcing, bespoke client solutions, ~60% margin. The platform compounded — AuM CHF-equivalent of roughly USD 127bn (2021) to USD 185bn (2025), dividend up every year. But the period closed with a credibility shock: on 10 March 2026 the shares fell 37% on an EPS miss the day after a record-revenue print, on 30 March co-founder Wietlisbach disclosed that CEO David Layton will step down in 2–3 years, and on 29 April Grizzly Research published a short report alleging the evergreen Master Fund's marks are "worse than Wirecard." The operating story has not bent; the trust in the operating story has.

1. The Narrative Arc

Partners Group was founded in 1996 in Baar by Alfred Gantner, Marcel Erni, and Urs Wietlisbach. The IPO came in 2006 at CHF 63 with USD 11bn AuM. Steffen Meister was CEO from 2005 to 2013 and is now Executive Chairman. David Layton became Co-CEO in 2018 and sole CEO in 2021 (after Christoph Rubeli's exit), running the firm from Denver and Zug. The present strategic chapter began in 2018 with the appointment of the first non-founder CEO and the platform crossing USD 100bn invested; it intensified in 2024 with the Empira real-estate acquisition, royalties as a fifth asset class, and the public AuM-to-USD 450bn-by-2033 target.

2. What Management Emphasized — and Then Stopped Emphasizing

Five themes anchor every Chairman & CEO letter: transformational investing, thematic sourcing, entrepreneurial governance, bespoke client solutions, and a stable ~60% margin. Around them, the catalog of "giga themes" has quietly turned over: Digitization, New Living, and Decarbonization filled 2021–2022; by 2025–2026 the language is dominated by AI / tech-enabled transformation, the Next-Generation Utilities energy transition narrative, and the Royalties Financing Revolution. Sustainability rhetoric peaked in 2022–2023 (Sustainability Strategy launch, DJSI inclusion) and has been visibly dialed down in the 2025 deck — still mentioned, no longer headlined.

3. Risk Evolution

The risk register has shifted from macro/exit-environment risks (2021–2023) to execution and credibility risks (2024–2026). Real-estate write-downs ran two consecutive years (-13.3% in 2023, -6.7% in 2024). Private credit was a "growth opportunity" in 2021–2023; by March 2026 Meister was telling the FT that default rates "could double in the next few years" — including from AI disruption to software borrowers. The newest and most acute risks — evergreen redemptions and short-seller scrutiny of valuation marks — were absent from the disclosures entirely until forced onto the agenda in late 2025 / early 2026.

The risks that emerged latest are also the risks management did not surface itself: the FT report of evergreen Master Fund net redemptions of USD 750m in Q3 2025 (double the prior year), and the April 2026 short report alleging close to 40% of evergreen investments may be "severely mismarked." Partners Group has framed evergreens as proof of its democratization moat for years; the credibility test on those marks is now external.

4. How They Handled Bad News

Three episodes show a recurring pattern: explain the miss as macro, hold the multi-year story, never apologize, defer the proof to next year.

5. Guidance Track Record

Partners Group does not give EPS or revenue point-guidance. The promises that matter are: annual fundraising range, performance-fee % of revenues, EBITDA margin band, AuM trajectory, and product/asset-class launches. The track record on these is, on balance, good but optically self-serving: when the firm misses (2022, 2023), it widens the time horizon ("mid- to long-term"); when it beats (2025), it re-bases the new guide upward (perf fees 20–30% → 25–40%).

Credibility score: 8 / 10 on what they said they would do, ~5 / 10 on what they did not say. Of seven measurable, settled valuation-relevant promises in the 2021–2025 period, six were delivered (some after being quietly re-anchored on a longer horizon). The real estate franchise is the one explicit underperform: two consecutive years of negative one-year direct returns, and the recovery thesis still depends on the Empira integration. The lower mark reflects what management did not surface in time: evergreen redemptions, the cost ramp behind the 2025 EPS miss, and the CEO succession plan. None of these were dishonestly hidden, but each became known to the market via a third party (FT, Bloomberg, Grizzly) rather than via Partners Group itself.

6. What the Story Is Now

The story management is selling in 2026 is the same operating story, rebuilt around AI/energy-transition themes, with two new structural ambitions: (a) USD >450bn AuM by 2033 driven by bespoke solutions, private wealth, and JV partnerships with BlackRock and Deutsche Bank; (b) IFRS 18 "performance income" of 25–40% of revenues as a steady contributor, on a more diversified base than the lumpy 2021 / 2025 prints. The story has, in fact, gotten simpler in business logic (five asset classes, two-pillar value creation, one client model) but more stretched in capital-markets terms — a 95% payout ratio, a 5% dividend yield because the share price has compressed, and an evergreen platform whose marks are now an external research subject.

What has been de-risked. The platform's recurring management-fee margin (1.18–1.33% range held for 19 years), the AuM compounding (USD 11bn at IPO to USD 185bn, ~13% CAGR over the recent decade), the dividend track record (CHF 2.65 → CHF 46.00, 16% CAGR p.a. since 2006), and the diversification of performance-fee sources (now 350+ programs vs reliance on a few flagship vintages).

What still looks stretched. Real-estate performance through-cycle; private-credit software exposure under AI-disruption stress (which Meister himself flagged); the perception risk around evergreen valuation methodology; and a CEO succession that will be unfolding precisely as the AuM-to-450bn ambition is meant to be tested.

What to believe vs. discount. Believe the platform mechanics — the recurring fee margin, the operating cadence, the realisations playbook in normal exit markets. Discount the management-defined narrative around the post-period events (cost ramp, evergreen redemption visibility, valuation marks) until two more disclosure cycles either rebut Grizzly cleanly or quietly migrate the methodology. The next 12 months are the credibility test, not the operating test — and the operating answer will not on its own settle the credibility question.

---

Financials — What the Numbers Say

1. Financials in One Page

Partners Group is a CHF 2.56B-revenue private-markets asset manager that turned roughly CHF 1.26B of that into net income (49% net margin) and CHF 1.51B into free cash flow in FY2025 — meaning more cash hit the bank than was reported as earnings. The business is asset-light: gross margin sits near 68%, EBITDA margin near 63%, ROIC near 35%, and capex is a rounding error (0.3% of revenue). Earnings power, however, is lumpy because performance fees swing with realisations — FY2021 revenue was CHF 2.63B, FY2022 was CHF 1.87B, and the platform took three years to recover. The balance sheet has flipped from net-cash to a modest net-debt position (CHF 485M, 0.30× EBITDA) as management funded record dividends and growth investments with bond issuance. The stock fell 37% on the day of the FY2025 print (10 March 2026) after management warned of lower 2026 management-fee guidance, leaving valuation at roughly 17–20× earnings — historically the cheap end of PGHN's own band. The metric that matters most right now is gross AuM raised in 2026, because management's own 2026 fee guidance and the USD 450B medium-term AuM target both depend on it.

How to read this page. PGHN is a fee-based asset manager, not a balance-sheet investor — so the income statement is more like a software company (high margins, light capex) while the balance sheet behaves like a small bank (bonds outstanding, dividends recycled). Treat management fees as the recurring annuity and performance fees as the wildcard.

---

2. Revenue, Margins, and Earnings Power

PGHN earns two revenue lines: management fees (a steady percentage of fee-paying assets under management — the annuity) and performance fees (a share of investment gains booked when underlying funds realise — the wildcard). The mix is roughly 60/40 in average years, but performance fees can swing from 25% to 50% of revenue depending on the year.

Revenue compounded at a 15% 10-year CAGR (CHF 619M in FY2015 → CHF 2.56B in FY2025), but the path was not linear. FY2021 was a once-in-a-decade realisation year — performance fees more than doubled and revenue jumped 63% YoY to CHF 2.63B. The two years after were a give-back: FY2022 revenue fell 29% as exits froze, FY2023 grew only 4%, and the platform only re-passed the FY2021 peak in FY2025.

The two lines move together, telling you operating expenses are largely variable — comp and carry payouts flex with the fee pool. That is why operating margin barely compresses even in down years: 56% in FY2011 (the worst trough) and 60–65% in normal years.

The remarkable feature here is stability. Operating margin has been a 56–65% band for a decade, with the lower end set in cyclical troughs (FY2011, FY2015, FY2022) and the upper end in heavy performance-fee years (FY2017–2018). The takeaway: PGHN's earnings power is fee-driven — if AuM keeps growing, the operating leverage will mechanically deliver, and the cycle controls the timing of when it shows up.

PGHN reports semi-annually, not quarterly. H2 is the seasonally bigger half because performance fees crystallise on full-year fund returns. H2 2025 was the strongest half on record (CHF 1.40B revenue, CHF 683M net income), yet the stock still fell 37% on the print — see Section 7 for why.

---

3. Cash Flow and Earnings Quality

Free cash flow is the cash a business generates after paying operating expenses and capital expenditures — the money truly available to return to owners, pay down debt, or reinvest. For a fee-based asset manager like PGHN, FCF should track net income closely because there is little physical capital to maintain.

That is exactly what happens over the cycle. Across the last decade, cumulative operating cash flow (CHF 8.92B) and cumulative net income (CHF 9.46B) are within 6% of each other. But the annual picture is bumpier because the cash-flow statement absorbs the timing of performance-fee receivables, deferred carry payouts, and the funding mismatch between when fees are booked and when they are received.

Look at FY2018 and FY2021 — both show OCF roughly half of net income. That is the receivables-build problem: revenue is recognised when fees are earned but cash arrives later when LPs settle. Both years were followed by a catch-up — FY2019 (OCF CHF 961M vs NI CHF 900M) and FY2022 (CHF 1.06B vs CHF 1.00B). The two lines reconnect over any rolling 2–3 year period.

Cash-flow distortion	What it does to reported earnings vs cash	FY2025 figure (CHF M)
Capex	Negligible — PGHN owns offices, not factories	-8.5
Stock-based compensation	Added back in OCF; real economic cost via dilution	+63.2
Dividends paid	Largest cash use; ~87% of net income	-1,091.9
Buybacks	Modest offset to dilution	-333.6
Net debt issuance	Funds dividend + working-capital needs	+353.8
Acquisitions	Tiny vs cash flow	-95.2

The story this table tells: PGHN is distributing the business rather than reinvesting in it — see Section 5.

---

4. Balance Sheet and Financial Resilience

PGHN's balance sheet looks more like a small bank than an industrial. Total assets are CHF 6.39B at FY2025 year-end, of which CHF 1.99B is cash and CHF 1.14B is receivables (mostly fees earned but not yet collected). On the other side: CHF 2.47B of debt, CHF 451M of payables, and CHF 2.19B of equity.

The structural shift is unmissable: PGHN ran with net cash of around CHF 1B for most of the last decade (negative net debt = more cash than debt), but since FY2022 has been steadily levering up — net debt swung from negative CHF 1.55B in FY2021 to positive CHF 485M in FY2025. Debt-to-equity climbed from 0.08 in FY2015 to 1.13 today. The driver is straightforward: dividend payments now exceed free cash flow, and the gap is funded by bond issuance.

Liquidity & resilience snapshot (FY2025)	Value
Cash and equivalents	CHF 1,986M
Total debt	CHF 2,471M
Net debt	CHF 485M
Net debt / EBITDA	0.30x
EBIT / interest expense (interest coverage)	17.0x
Current ratio	1.67
Quick ratio	0.85
Long-term debt / equity	0.65
Intangibles / total assets	5.7%

---

5. Returns, Reinvestment, and Capital Allocation

PGHN earns spectacular returns on the capital it uses — ROE 35–55% and ROIC 35–77% for the last decade — because the business model uses very little capital. The team manages CHF 165B+ of client assets while keeping only a few hundred million of working capital on the books. That is the asset-light asset-manager structure at its purest.

ROE has actually risen in the past two years even as ROIC has fallen — that is a sign of financial engineering, not operational improvement. Lower equity (denominator) plus more debt (gross capital up) flatters ROE while dragging ROIC. The underlying ROA is steady at 21%.

The chart makes the policy explicit: dividends do almost all the work. Cumulative FY2015–FY2025 distributions: CHF 7.31B of dividends + CHF 3.70B of buybacks vs CHF 9.91B of cumulative net income — a 111% payout ratio over the decade. PGHN is, by design, an income vehicle for shareholders.

The dividend has been raised every year for 17 consecutive years (DPS CHF 8.52 in FY2015 → CHF 42.12 in FY2025, an 11.3% 10-year CAGR), even when EPS fell. The payout ratio has now climbed to 87% — leaving little buffer if performance fees disappoint. Share count is roughly flat to slightly down (26.3M → 25.8M over a decade) because buybacks roughly offset employee equity grants.

---

6. Segment and Unit Economics

Detailed segment-level revenue is not available in the fundamentals feed for PGHN — Swiss filers disclose less segment granularity than US peers. The business model reporting from the company itself splits assets and revenue into four asset classes (private equity, private debt, private real estate, private infrastructure) and two fee types (management fees vs performance fees). Investor releases describe these splits qualitatively rather than line-by-line.

What the company does disclose at the asset-class level (from the FY2025 annual presentation):

Dimension	What you need to know
Private equity	The largest asset class, ~50% of AuM. Drives the bulk of carry/performance fees.
Private debt	Roughly 25% of AuM. Steadier management fees, less performance-fee upside.
Private real estate	~12% of AuM. Cyclical with property values.
Private infrastructure	~13% of AuM, but the fastest-growing pillar — data-centres are an explicit focus.
Customised mandates	~70% of AuM is in bespoke client mandates (this is where Hamilton Lane is the closest peer).
Evergreen / wealth	New retail-channel vehicles (PG ENG, PG Direct Equity Evergreen) — the platform Blackstone pioneered with BREIT/BCRED.

The economics that matter: management fees scale roughly linearly with AuM (~1% blended fee rate on fee-earning AuM), while performance fees scale with realised gains and can run from 10% to 35% of total revenue in any given year. The "wildcard" is realisations — i.e., when portfolio companies are sold or refinanced — and 2022–2024 was a thin window for realisations across the entire private-markets industry.

---

7. Valuation and Market Expectations

PGHN trades at 17.7× trailing P/E and ~14.8× P/FCF at the recent price near CHF 859 (May 2026). Those are the cheap end of its own 15-year history — only the 2008 crisis and the brief 2022 drawdown saw lower multiples.

Three things to notice:

1. The 5-year P/E median is roughly 27×. Today's 17–20× is a one-third discount to that, in line with the FY2022 trough.
2. EV/EBITDA has compressed harder than P/E because net debt has appeared on the balance sheet (Section 4). The multiple of 16× is the lowest reading since FY2008.
3. P/FCF is also at a 15-year low, but FCF is unusually high in FY2025. Normalising to a 5-year average FCF would lift P/FCF closer to 23×.

The market is pricing PGHN as if its earnings power is permanently lower. The most direct evidence for why: on 10 March 2026, the company published FY2025 results plus 2026 guidance that warned of lower management fees in 2026 (a function of AuM mix shift and fee-rate dilution from the bigger customised mandates) — and the stock fell 37% from CHF 1,289 to CHF 806 on the day. The recovery since then has been partial.

Consensus price target sits at CHF 1,150 — a ~34% premium to current price. The bear-case (Citi, CHF 940) still implies modest upside, and the bull-case (Kepler, CHF 1,260) implies ~47%. There is no analyst short call on this name today.

Simple bear / base / bull (CHF per share, 12-month)	EPS	Multiple (×)	Price	Implied return
Bear — FY2026 EPS down 10%, multiple stays at 15×	43.6	15	654	-24%
Base — FY2026 EPS up 6% in line with mgmt guide CHF~51, multiple 18×	51.4	18	925	+8%
Bull — FY2026 EPS up 12% to CHF~54, multiple re-rates to 22×	54.0	22	1,188	+38%

The valuation supports a base-case total return of ~13% (dividend yield 5% + 8% price appreciation) and a more attractive bull-case (~43% with dividend). The bear-case (-24% before dividend) requires a multiple compression plus an earnings miss, and is closer to a worst-case than a likely-case.

---

8. Peer Financial Comparison

PGHN's natural peer set is European-listed private-markets pure-plays (EQT, Bridgepoint) and the US alternative-asset giants (Blackstone, KKR, Apollo, Ares, Brookfield, Carlyle). Hamilton Lane is the closest economic analogue for the customised-mandates business. All figures are FY2025 (or FY2026 for HLNE, which has a March fiscal year-end).

Strip out the headline numbers and the picture is clear. PGHN has the highest operating margin (60%), the highest ROE (55%), the highest ROIC (35%), and the lowest net-debt-to-EBITDA (0.30×) of any pure private-markets peer. It also has the lowest P/E and EV/EBITDA among the European pure-plays and US giants — at 20× P/E, it trades cheaper than EQT (55×), Bridgepoint (58×), Blackstone (40×), KKR (50×), Apollo (26×), and is only matched by Hamilton Lane (17×, but on lower-margin economics). The 4.3% dividend yield is bested only by Ares (5.0%) and Blackstone (5.0%).

The puzzle: PGHN has better fundamentals than EQT or Blackstone on every single line of this table — and trades at half their multiples. The market is paying for growth (EQT's 30% 5-year revenue CAGR vs PGHN's 13%) and scale (BX's USD 1T+ AuM). PGHN's pitch is quality per dollar of revenue, not size.

---

9. What to Watch in the Financials

Metric	Why it matters	Latest value	Better	Worse	Where to check
Gross AuM raised (annual)	Determines management-fee growth — the annuity	CHF ~30B fundraising 2025	Above CHF 35B in 2026	Below CHF 25B in 2026	Half-year and annual reports
Total AuM	Direct lever on revenue	CHF 165B (USD 185B)	Compounding toward USD 450B target	Flat or shrinking	AuM-update press releases (April/October)
Management-fee growth (YoY)	Cleanest read on the recurring engine	~+10–12% est. for 2025	Re-accelerates to 12–15% in 2026	Falls below mid-single-digits	Earnings call commentary on fee guidance
Performance fees as % of revenue	Drives EPS volatility	~35% in FY2025	Stable 30–40% range	Spikes above 50% (one-off) or collapses below 20%	Annual report fee breakdown
FCF / Net income (rolling 2Y)	Tests whether profits become cash	1.0x rolling 2Y	Sustained at 0.9–1.1×	Persistent below 0.7×	Cash-flow statement
Net debt / EBITDA	Tests dividend sustainability	0.30×	Stable below 0.5×	Climbs above 1.0×	Balance sheet vs EBITDA
Payout ratio	Reveals dividend safety	87%	Returns to 70–75% (earnings catch up)	Climbs above 100% (uncovered)	Annual report DPS line vs EPS
Effective fee rate on AuM	Detects mix-shift fee compression	~1.0% blended	Stable or rising	Falls below 0.95%	Half-year supplemental

The financials confirm three things: PGHN earns top-tier returns on tiny capital, the dividend is generous, and the platform has compounded AuM at a double-digit pace for 15+ years. They contradict the recent 37% stock drop — there is nothing in the FY2025 income statement, cash-flow statement, or balance sheet that explains a value destruction of that magnitude. The market is pricing a multi-year fee-growth slowdown that has not yet appeared in the printed numbers.

The first financial metric to watch is management-fee growth in the H1 2026 print (out August 2026). Management's own guidance flagged 2026 as a soft year; if reported H1 2026 management fees grow above mid-single-digits, the bear thesis weakens materially. If they grow below 5%, the 37% sell-off was warranted and the multiple has further to fall.

---

Web Research — What the Internet Knows

The Bottom Line from the Web

The dominant web story is a credibility crisis the filings do not yet show. On Mar 10, 2026, PGHN crashed 37.47% in a single session (CHF 1,289 → CHF 806) despite a +20% revenue print and a record USD 184.9bn AuM — the market read the FY25 details (pulled-forward performance fees, 2026 guidance to the lower end of 25-40% performance-fee range, IFRS 18 noise) as a warning. Seven weeks later, on Apr 29, 2026, Grizzly Research published a short report alleging Wirecard-scale mismarking in PGHN's evergreen book — the Master Fund and PG Investment Co. positions. PGHN's rebuttal is sharp but litigation-toned, and within days co-founder Urs Wietlisbach told Bloomberg that CEO David Layton would step out of the role within 2-3 years. None of this is in the financial statements; all of it should be in the investor's view.

What Matters Most

Key Metrics from Web Research

Recent News Timeline

Analyst Action Snapshot

What the Specialists Asked

Governance and People Signals

Founders & ownership. Three founders (Marcel Erni, Alfred Gantner, Urs Wietlisbach) each own ~5.02-5.08% directly; combined ~15.12% (~CHF 5.7bn at current price). Top external holders: BlackRock 5.20% (1,340,353 sh), UBS Asset Management 5.19% (1,336,968 sh). Treasury: 916,870 sh (Dec 2025) vs 795,970 sh (Dec 2024). Tight float — only 26.7m shares in issue. Per a Glassdoor ex-employee, "less than 20 people including former and retired partners own over 40% of share capital" — concentrated, employee-aligned ownership.

Board. 7-member board: Executive Chairman Steffen Meister (CEO 2005-2013), three founder Executive Directors, and three independents — Urban Angehrn (Lead Independent, former FINMA CEO Sept 2021-Sep 2023, former Group CIO Zurich Insurance), Anne Lester (ex-JPMorgan AM Global Head Retirement Solutions), Gaëlle Olivier (ex-AXA P&C CEO, ex-SocGen Deputy GM/COO). ISS Shareholder Rights pillar score 9 (highest risk) is the standout concern.

Compensation. Layton total CHF 1.87m cash 2025 (Simply Wall St cites CHF 15.93m including LTI). Founder Exec Director cash comp deliberately modest at CHF 351-352k each; wealth comes from equity (stock ~12x since 2006 IPO). LTI Share-based Performance Plan grant ratio cut to 50% from 67%. 65% of carried interest accrues to the listed PGHN AG; employees from VP level receive carry vesting 20%/year over 5 years; full forfeit on 2-year non-compete breach.

Insider transactions (90d to May 2026).

Source: https://www.insiderscreener.com/en/company/partners-group-holding-ag (note: aggregate insiderscreener data; individual-named SEC Form 4 filings are limited because PGHN files in Switzerland, not the US — most US-side disclosures relate to PGHN-affiliated US fund vehicles like the May 2026 USD 15.5m sale of Life Time Group Holdings shares).

Layoffs and people stress.

Industry Context

The web adds three structural overlays the Industry primer would not have:

1. Private credit is the sector's pressure point — and PGHN's chairman just said the quiet part out loud. Steffen Meister's FT interview (Mar 12, 2026) warned default rates "could double over the next few years" as AI disrupts software-borrower credit. BofA followed with a Mar 17, 2026 short pitch on European stocks with PE/PC exposure (named PGHN and Deutsche Bank with up to 30% downside). Reuters (Apr 3-6, 2026) ran broader "private-credit sector stresses could be catastrophic — but not just yet" coverage. The industry framing has flipped from growth opportunity to risk concentration in under six months.

2. Wealth/retirement distribution is consolidating around a small number of relationships. The BlackRock + Partners Group SMA (Jan 2026) is "first-of-its-kind," and BlackRock manages over USD 250bn in SMAs and USD 34bn in PE commitments. Deutsche Bank's DWS partnership (Q3 2025), Erste AM (CEE, Dec 2025), Mediobanca (Italy royalties, Nov 2025), Lincoln Financial (US royalties, Sept 2025), and PGIM (Apr 2026, USD 1.44trn AuM) all chose PGHN. The democratization wave is real, and PGHN is over-represented relative to its size on the distributor short-list.

3. Royalties as the next asset class. PGHN frames the global royalty TAM at ~USD 2trn (Outlook 2026), targets over USD 30bn AuM by 2033 from a USD 1.5bn base, and launched the world's first cross-sector royalty offering in evergreen structures in 2025. Mediobanca's Italy launch (Nov 2025) and Lincoln's US fund (Sept 2025) are early distribution wins. No comparable peer focus identified — early-mover claim is credible.

McKinsey's Global Private Markets Report 2026 framing — "Clearer view, tougher terrain" — captures the consensus: outcomes now driven by deal sourcing, operational value creation, and longer holds rather than asset-class beta. PGHN's positioning (67% bespoke, 60% direct, vertically integrated) is well aligned with that thesis, but the Grizzly allegation tests whether the underlying value-creation marks are real.

---

Web Watch in One Page

Partners Group enters the next reporting window with the operating engine intact (record FY25 print, 17th consecutive dividend raise) but the multiple anchored to a single open question — whether the Level-3 marks in the evergreen book survive contact with realised exits. The five active watches are built around that question and the four next-tier thesis variables the report flags: regulator action on the Grizzly thesis, the H1 2026 constant-currency management-fee print, wealth-channel partnership economics, and the CEO succession process. Together they cover the report's single decisive variable (mark credibility), its two long-term thesis pillars (fee-margin defence and the wealth-channel build), and its two governance overhangs (regulator tail risk and CEO transition) without duplicating coverage.

Active Monitors

Rank	Watch item	Cadence	Why it matters	What would be detected
1	Evergreen exit proceeds vs last reported NAV + Master Fund N-CSR + PwC auditor opinion	Daily	The decisive variable in the verdict. A confirmed below-mark exit on Apex Logistics, STADA or atNorth, or a fair-value emphasis-of-matter from PwC, invalidates the moat claim and re-anchors the multiple to the EQT/Carlyle band.	Realised proceeds versus last reported NAV on the three named exits; Master Fund FY-March-2026 N-CSR opinion text; Level-3 KAM language; any second N-CSRS amendment.
2	Regulator inquiry (FINMA, SEC, BaFin) + second independent short report	Daily	Highest-severity tail risk. A formal probe or a second short shop corroborating Grizzly would force re-underwrite of every operational claim simultaneously; absence is itself bullish for the bull side.	New FINMA, SEC or BaFin enforcement steps, on-site reviews, or public probes; a second independent short publication; Grizzly Research follow-up or addenda.
3	H1 2026 prints — constant-currency mgmt-fee growth, Master Fund flows, IFRS 18 reconciliation	Daily	The annuity-bend test. A sub-7% constant-currency print or a Master Fund gating event would break the ten-year fee-margin band that anchors the bull case.	15 July AuM announcement; 1 September H1 interim; gross-demand pacing versus the USD 26–32bn FY26 guide; evergreen net-flow direction; IFRS 18 restated comparatives.
4	Wealth-channel partnership AuM and fee economics (BlackRock–MS SMA, DB ELTIF, PGIM, Generali, Mediobanca, Erste, Lincoln)	Weekly	The five-to-ten-year thesis driver. If distributors take economic share above 30% of the management fee, the 118–133 bps margin band compresses toward 110–115 bps over the AuM-to-USD-450bn build.	Discrete wealth-channel AuM disclosure; partner fee splits visible to PGHN versus the distributor; new wealth-platform launches; first-12-month accrual on the BlackRock–Morgan Stanley SMA.
5	CEO succession, senior team departures, founder insider tape	Bi-weekly	The governance overhang flagged when Wietlisbach signalled Layton's 2-3 year exit. External-search risk and key-person departures during the wealth-channel scale-up re-price execution risk on the long-term thesis.	Internal successor announcement; opening of an external CEO search; departure of Jenkner, Gröflin, or Marquardt; founder net-selling above CHF 10m via SIX or EQS News.

Why These Five

The report's verdict — Lean Long, Wait For Confirmation — turns on whether the September 2026 H1 interim clears the three named exits at or above last reported NAV. Monitor 1 catches that resolution as it lands, plus the third-party PwC opinion on the Master Fund N-CSR that arrives weeks earlier. Monitor 2 covers the lowest-probability, highest-severity tail: a regulator probe or a second independent short report would invalidate the bull's moat claim without waiting for any company-controlled disclosure. Monitor 3 watches the company-controlled answer to the annuity-bend question (constant-currency management-fee growth, evergreen net flows) at the two dates the report identifies as decision-relevant. Monitors 4 and 5 step outside the next-90-day window to the two five-to-ten-year thesis pillars the report names as the durable tests — wealth-channel partnership economics for fee-margin defence, and the CEO succession process for execution risk during the wealth build. Together the set covers every "what would change the view" item in the report and leaves no overlap between watch items.

---

Where We Disagree With the Market

The market is applying evergreen mark-credibility risk to the entire AuM base, even though 67% of fee-paying AuM sits in bespoke mandates that have never been the subject of mark allegations and where the 118-133 bps management-fee margin band has held for ten years. Consensus has re-rated PGHN from 28x to 17.7x trailing P/E in 90 days on three overlapping anxieties (a FY26 perf-fee guide reset, Grizzly's evergreen marks claim, and a CEO succession leak), but the de-rating treats every fee dollar as if the entire franchise is on trial. Two further disagreements compound this: reported CHF management-fee growth (+7%) is being read as the franchise compounding rate when the constant-currency print is +12%, and FY25 free cash flow (CHF 1,506m) actually exceeded net income (CHF 1,261m) for the first time in six years even as bears anchor on a multi-year debt-funded payout narrative. The decisive resolution is the 1 September 2026 H1 interim where constant-currency management-fee growth, the three named evergreen exit proceeds, and the IFRS 18 restated comparatives all print in the same release. If two of those three clear, the de-rating was wrong.

Variant Perception Scorecard

The 62 variant-strength reflects three observable disagreements with consensus, each measurable in a single H1 2026 print, against a backdrop where the market itself has not settled (analyst PT range CHF 930-1,300, 6 Buy / 6 Hold). Consensus clarity is mid-range because the 37% one-day re-rating is a clear signal of a treat-as-permanent reset, but the dispersion of price targets means there is no single "consensus number" to argue against — only a directional treatment of FY25 as a cycle peak. Evidence strength is the higher of the three scores because every variant claim has a falsifiable counter-test in the September interim, and the per-position rebuttal facts (three named exits, PwC opinion, founder buying, fee margin band) are already on the public record.

Consensus Map

The market view is not monolithic, but the directional consensus is unambiguous: PGHN's FY25 print is being treated as a cyclical peak on a contested moat, with the September 2026 interim as the next reset point. The high-confidence cells are the earnings-quality and capital-structure reads (rows 1 and 6) where the dispersion among sell-side analysts is narrow; the medium-confidence cells are the marks, wealth-channel, and succession reads where consensus has split and the next disclosure cycle changes the picture in either direction.

The Disagreement Ledger

Disagreement 1 — Risk attribution. Consensus would say the Grizzly allegations attack the entire bespoke premium because trust in one segment's marks is trust in the whole. The report's evidence pushes back on two grounds: mandate AuM (37% of total) is contractually integrated with LP back-office and has no public mark allegation against it, and the management-fee margin band that anchors valuation is computed on the blended book and has held across all four market regimes of the last decade. If the September H1 interim confirms the three named exits at or above mark and the constant-currency mgmt-fee print holds above 10%, the market has to concede that the de-rating priced cross-contamination that did not occur. The cleanest disconfirming signal is a single contested exit proceeds disclosure below last reported NAV.

Disagreement 2 — FX-masked compounding. Consensus reads single-digit reported CHF mgmt-fee growth as evidence the annuity is bending under wealth-channel mix pressure. The constant-currency disclosure tells a different story (+12% FY25 vs +7% reported) — the gap is real CHF strength against USD/EUR, not pricing concession. The market would have to concede that the franchise has been compounding at a rate consistent with the 11.7% AuM CAGR target if the H1 2026 print shows constant-currency mgmt-fee growth >10% with an explicit reconciliation in the IFRS 18 restated comparatives. The cleanest disconfirming signal is two consecutive halves of constant-currency mgmt-fee growth below 7% — at that point the bend is real, not translation.

Disagreement 3 — Cash conversion inflection. Consensus frames a 95% payout funded by net debt issuance as a stretched capital structure with no cushion. FY25 specifically broke that pattern: FCF exceeded net income by 19%, DSO compressed 35 days, and the cumulative FY24-FY25 OCF/NI is back to 1.0x. The market would have to concede that the FY24 DSO blow-out was working capital, not earnings quality, if the H1 2026 print shows DSO below 150 days and net debt / EBITDA staying below 0.5x without a parallel acquisition or unusual financing line. The cleanest disconfirming signal is DSO reverting above 180 days in H1 2026 while net debt / EBITDA crosses 0.8x.

Disagreement 4 — Succession process vs uncertainty. Consensus is pricing the 2-3 year transition window as an unspecified discount because the leak came from a co-founder, not a formal succession announcement. The report's evidence is that the firm has done this before successfully and the bench is already named — Jenkner and Gröflin are in seat, the ExMCP carry vests overlap the transition window, and an ex-FINMA CEO sits on the audit committee. The market would have to concede this overhang is mispriced if PGHN names an internal successor within 12 months without an external search disclosure. The cleanest disconfirming signal is an external CEO search announcement or a departure of Jenkner, Gröflin or Marquardt.

Evidence That Changes the Odds

The seven items above are the evidence that actually moves the probability of the variant view, not the broad inventory of facts in the upstream tabs. Rows 1, 4 and 5 are the strongest because they are direct counter-tests to the bear case — pricing power holding, a clean audit during a contested year, and realisation pace materially above industry. Rows 2 and 3 are the FY25-specific cash and behavioural anchors that invalidate the "no cushion" framing. Rows 6 and 7 are the compounding-math anchors that the September interim and the FY26 print can falsify.

How This Gets Resolved

What Would Make Us Wrong

The cleanest way to be wrong on the bespoke-versus-evergreen risk attribution is for the Master Fund FY-March-2026 N-CSR (late May / early Jun 2026) to land with a PwC emphasis-of-matter paragraph on fair-value measurement, or for any one of the three named exit proceeds (Apex Logistics, STADA, atNorth) to come in materially below the last reported NAV in the September H1 interim. Either outcome would mean the 67% bespoke share of AuM is not insulated from the marks-credibility cascade — clients of bespoke mandates would re-underwrite the trust premium they pay for, and the 118-133 bps margin band would compress within one or two reporting cycles. The forensics tab already grades the firm at a 52/100 risk score with four red/yellow flags around Level-3 discipline; the variant view sits on top of a real, unresolved scope question.

The cleanest way to be wrong on the FX-masked compounding leg is for the H1 2026 constant-currency management-fee print to land below 7% with a clean reconciliation under IFRS 18. That outcome would mean the +12% FY25 constant-currency number was inventory-driven (Empira's USD 4bn fee-paying AuM one-shot), not run-rate, and the underlying compounding has already bent. Two consecutive halves below 7% would invalidate the bull's 11.7% AuM CAGR target by implying the wealth-channel partnership economics are flowing through to the average margin faster than acknowledged. The catalysts tab explicitly names this as the bend-vs-no-bend test — and one half of evidence is not enough; it needs a pattern.

The cleanest way to be wrong on the cash conversion inflection is for FY25's FCF/NI of 1.20x to be a single-year working-capital catch-up — the FY24 DSO blow-out unwinding once — followed by reversion to the multi-year ~0.83x average in FY26 as performance fees mean-revert. That would mean the cumulative debt-funded payout framing was correct and FY25 was the optical aberration, not the inflection. The forensics tab already flags this as a Yellow on Cash Flow Quality; if Q3 2026 trading update or the September interim show capex still at sub-CHF 10m levels alongside a fresh receivables build, the inflection was illusory.

And the cleanest way to be wrong on the broad variant view is the lowest-probability but highest-severity outcome: a FINMA, SEC or BaFin inquiry into the Level-3 valuation methodology — none disclosed as of 24 May 2026, but the absence is not proof. A regulator action would force a re-underwrite of every claimed defensive observation simultaneously and the bespoke/evergreen attribution would not survive the cascade. This is the single tail risk that the report's evidence cannot pre-emptively defend against.

The first thing to watch is the Master Fund FY-March-2026 N-CSR with PwC's audit opinion (late May / early Jun 2026) — the first third-party verdict on the Grizzly thesis before any company-controlled disclosure cycle.

---

Liquidity & Technical

PGHN is institutionally tradeable at normal mandate size — a CHF 22.3B Swiss equity turning over roughly three-quarters of float annually with CHF 91M of daily traded value clears a 5% position for funds up to about CHF 1.8B AUM inside five sessions — but the tape is decisively bearish: price sits 11.5% below the 200-day, the most recent 50/200 cross was a death cross in April 2025 that has not reverted, and shares are pinned in the bottom fifth of the 52-week range. The single feature that matters most is that every meaningful volume spike of the past two years closed red — distribution, not accumulation.

Portfolio implementation verdict

Price snapshot

The trend chart — full ten-year price with 50d / 200d SMA

Caption. The ten-year view tells one story: a 2020–2021 melt-up from CHF 700 to CHF 1,650, a two-year base around CHF 1,000, a 2024 retest of the highs, and a clean downtrend since February 2025. Today's CHF 859 is below both moving averages and sub-200-day for 13 months running — this is a downtrend regime, not a correction inside an uptrend.

Relative performance — 3 years rebased to 100

Caption. A round-trip back to the May-2023 starting point, with the rollover beginning February 2025 — coincident with the broader cooling in private-markets fundraising and the April 2025 death cross.

Momentum — RSI(14) and MACD histogram (18 months)

Caption. RSI ended at 40.9 — neutral but trending lower — having failed to break above 70 in April 2026 (which would have signaled a fresh leg up). MACD histogram has just flipped negative again after a brief positive run, mirroring the failure of the recent rally to take out the 200-day. Near-term momentum is rolling over, not bottoming.

Volume, sponsorship, and volatility

Caption. The dominant signal is volume on the down days. Of the five largest volume spikes on record, four (2020-03-12 COVID, 2024-09-03 −9.2%, 2025-04-07 −9.7%, 2020-09-18) printed sharp losses — that is distribution, not accumulation. Realized vol at 28.8% sits between the 50th-percentile (21.3%) and 80th-percentile (32.5%) bands — the market is demanding a wider risk premium than during 2023's calm period, but is not yet pricing capitulation. The April 2025 vol spike to 55% remains the most recent stress event.

Institutional liquidity panel

This panel is for buy-side firms sizing a real position. The data manifest flags PGHN as "Illiquid / specialist only" because no issuer-level position from 0.5%–2% of market cap clears in five trading days at the 20%-ADV participation cap. From a fund-AUM perspective, the picture is materially better: at normal portfolio weights (2%–10%), the stock supports funds well into the billions. Read the verdict as "capacity-constrained for concentrated owners, fine for diversified mandates."

ADV & turnover

Fund-capacity table — how big a fund can run a position?

Liquidation runway — how long to exit an issuer-level position?

Daily-range proxy. Median 60-day daily range is 0.90% — well under the 2% impact-cost threshold, indicating intraday execution friction is low. Algo execution at VWAP or TWAP over multi-session windows should clip well inside that band.

Bottom line on liquidity. At 20% ADV participation, the largest issuer-level position that can be liquidated in five sessions is roughly 0.4% of market cap (CHF 89M) — not 0.5%, hence the manifest flag. At 10% ADV, that drops to 0.2% (CHF 45M). On the fund-portfolio axis, a generalist long-only running a 5% position weight has clean execution up to roughly CHF 1.8B AUM at 20% ADV, CHF 894M at 10% ADV. Funds materially larger than that — or concentrated owners eyeing 1%+ of the company — face real multi-week execution windows.

Technical scorecard

Stance — bearish on a 3–6 month horizon

Bearish. Aggregate scorecard is -5 of -6 — every dimension except volatility is negative. The tape confirms what a sober fundamental read of the private-markets asset managers already suggests: AUM growth is cooling, performance-fee earnings are compressing, and the multiple is de-rating along with the trend. Two levels will define the next leg:

• Above CHF 970 (the 200-day SMA): a daily close above this — ideally with confirming volume — would mark a real regime change and flip the trend score to neutral. A push through CHF 1,030 (the late-Jan-2026 high) would confirm the reversal.
• Below CHF 785 (the 52-week low): a break opens the path to CHF 700 / CHF 660 (mid-2022 lows), and would force a forensic re-read of the fundamental thesis. ATR(14) of CHF 13.7 means a typical week can carry CHF 50–70 of range — the cushion to support is only ~9%.

Liquidity is not the constraint; conviction is. The right tactical action is watchlist with limit orders at CHF 800 and CHF 760 rather than an at-market build. Patient accumulation over multiple weeks at 10% ADV is feasible for funds under CHF 900M (5% weight), and the daily-range profile keeps execution cost low — but there is no technical evidence yet that the downtrend has bottomed, and chasing here means catching a knife that the tape is still actively dropping.

---

Short Interest & Thesis — Partners Group Holding AG (PGHN)

Bottom Line

Reported short interest is not decision-useful here. The short thesis is. Switzerland has no FCA- or BaFin-style public regime for daily aggregated or holder-level net-short positions on SIX-listed equities, so there is no official short-interest series to read for PGHN. Borrow-cost and utilization indicators are paywalled. What is visible — and material — is the Grizzly Research short campaign published 29 April 2026 alleging mismarks on roughly 40% of the evergreen book, BofA's 17 March 2026 sell-side short pitch on European listed-alt names including PGHN, and a tape that already moved with these events (-37.47% on 10 March 2026, -5% intraday on the Grizzly publication). The unresolved thesis risk is around Level-3 NAV honesty, not crowding.

Reported Positioning — What the Official Data Says

Status: unavailable, by regime. Swiss disclosure law requires shareholders to disclose long threshold crossings (3%, 5%, 10%, etc. per FINMA / SIX Disclosure Office), but Switzerland does not publish daily aggregate short interest or holder-level public net-short positions in the way the UK FCA (≥0.5%) or BaFin (≥0.5%) do. The deterministic short-interest staging step returned zero rows for the Swiss market and recorded "No deterministic official/public short-interest fetcher is configured for this market in v1." (data/short_interest/source_manifest.json).

The institutional implication: a PM cannot read "short interest %" or "days to cover" off a SIX disclosure feed for PGHN — both numbers would have to be sourced from a paid securities-lending vendor (Markit, S3 Partners, ORTEX, IBKR), and even those are estimates. Anyone quoting a precise short-interest figure for PGHN is quoting a vendor estimate, not an official tape. Treat unsupported "% of float short" numbers as inference, not fact.

The Short Thesis That Is Public — Grizzly Research, 29 April 2026

Grizzly Research, a US-based short-biased research firm, published a 100+ page report on PGHN on 29 April 2026 stating "we are short Partners Group Holding AG" (size of position not disclosed) and alleging that close to 40% of the evergreen book may be severely mismarked. Source class: short-seller allegations. The publication day saw an intraday move of roughly -5% in PGHN; the company published a forceful written rebuttal on 30 April 2026 ("frivolous, defamatory, and highly misleading") and said it is "exploring legal action over suspected market manipulation."

The honest read: PGHN's rebuttal was fast and forceful but narrow — it disputes scope (evergreen revenue share), methodology (software-exposure definition) and a handful of named positions (Apex, STADA, atNorth) with exit evidence, while the position-by-position marks on Forterro, Unit4, Afileon and the data-center operator have not been answered publicly. KPMG was re-elected Swiss group auditor at the 20 May 2026 AGM, PwC remains auditor of the US Master Fund (unqualified opinion 30 May 2025), and no regulator has opened a public probe as of the report date. The thesis is unresolved, not refuted.

The Other Public Short Signal — Sell-Side Pitch

A second, lower-volume short signal came from BofA on 17 March 2026 (after the 10 March -37.47% crash), pitching shorts on European listed alternatives with private-equity / private-credit exposure — PGHN was named alongside Deutsche Bank with downside guided up to 30%. Five days earlier, Chairman Steffen Meister told the FT that private-credit default rates "could double over the next few years" as AI disrupts software borrowers — an unusually candid public risk warning from the chair of a USD 40bn PC book.

The pattern is a credibility cascade: fundamental reset on 10 March → chair risk language on 12 March → sell-side short pitch on 17 March → broker PT cuts → public short report on 29 April. Each step is from a distinct source class; the Grizzly report did not create the move, it landed into a tape already discounting bad outcomes.

Crowding vs Liquidity — What We Can Infer Without Vendor Data

We have no short-interest count, but we have a complete liquidity stack (data/tech/liquidity.json). The combination tells us whether any meaningfully large short would face structural cover difficulty, even without knowing whether such a short exists.

The inference, expressed carefully: even without a short-interest count, the structural setup is one in which a meaningful short would be hard to cover. If a hypothetical short of 2% of market cap (≈CHF 447M, 520,000 shares) existed, it would take roughly 5 trading days to cover at 20% ADV participation and ~10 days at 10% ADV. Pair this with a tight ~22m tradeable share count, 15% locked-up founder stake, and only 9% of cushion before the 52-week low — the liquidity profile amplifies any positioning event without telling us positioning is crowded today. The label "crowded short" cannot be confirmed without vendor data.

Borrow Pressure — What Can Be Said Publicly

Status: unavailable in public data. PGHN is included in major MSCI/SPI indices, has lendable supply from large index-fund and pension holders (BlackRock 5.02%, UBS Fund Management 5.01%, Capital Group 3.01%), and Interactive Brokers' Securities Lending dashboard exposes utilization and fee figures only behind a client login. The public-source review surfaced no hard-to-borrow flag, no recall events, and no specific borrow-cost data point for PGHN.NF / PGHN.S. The reasonable working assumption — without vendor data — is that PGHN is broadly borrowable given the large institutional lender base, with no evidence of a locate-friction event around either the Mar-10 print or the Apr-29 Grizzly publication. This is an absence of evidence, not evidence of absence; a desk wanting precision should pull a Markit / S3 / ORTEX snapshot.

Market Setup — How Short Activity Sits With Catalysts

Asymmetry read. The squeeze case is structurally weak: there is no public short-interest count to claim crowding, the tape is in a confirmed downtrend with thin overhead supply, and the next dated catalyst (H1 2026 interim report) is months out. The de-risk case is structurally stronger: if H1 2026 disclosures confirm the contested exits at-or-above mark, the short narrative loses its strongest single piece of evidence in one print — and the structural cover difficulty (tight float, locked-up founders, low ADV) amplifies the response. Insider buying of CHF 33.7m net (90d) is a reverse signal against the short thesis.

Source-Class Discipline

For any reader who comes to this page wanting a single "short interest %" number: the honest answer is that none can be cited from official Swiss data, and any number circulating is from a paid vendor estimate. The discipline below keeps source classes separate per the agent contract.

Evidence Quality and Limitations

Recommendation to the PM

For position sizing, the operational answer: treat reported short interest as not decision-useful for PGHN; treat the short thesis as decision-useful and unresolved. The single highest-leverage piece of evidence between now and the H1 2026 interim report is the realized exit price of the three positions PGHN named in its 30 April 2026 rebuttal (Apex Logistics, STADA, atNorth) versus the last reported marks. If the exit proceeds confirm the marks, the Grizzly thesis weakens materially and the structural cover difficulty (tight ~22m tradeable share count, 15% locked-up founder stake, low 0.41% ADV/mcap) turns into a tailwind for the long side. If a single exit lands meaningfully below mark, the thin 9% cushion to the 52-week low becomes the relevant number, not any short-interest count.

For a long PM, this is a margin-of-safety adjuster, not a thesis-breaker. For a short PM, the asymmetry runs the other way: the thesis carries head-line credibility but the cover mechanics are unattractive without an independent corroborating disclosure event.